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Damage to articular cartilage, whether through degeneration (i.e. osteoarthritis) or
acute injury, is particularly debilitating due to the tissue’s limited regenerative capacity.
These impairments are common: nearly 27 million Americans suffer from osteoarthritis
and 36% of athletes suffer from traumatic cartilage defects. Allografts are the preferred
treatment for large cartilage defects, but demand for these tissues outweighs their sup-
ply. To generate additional replacement tissues, tissue engineering strategies have been
studied as a cell-based alternative therapy.
Our laboratory has had great success repeatedly achieving native or near-native
mechanical and biochemical properties in grafts engineered from chondrocyte-seeded
agarose hydrogels. The most common iteration of this technique yields a disk of ˜4 mm
diameter and ˜2.3 mm thickness. However, much work is still needed to increase the
potential for clinical translation of this product. Our laboratory operates under the
premise that in vivo success is predicated on replicating native graft properties in vitro.
Compared to these engineered grafts, native grafts are larger in size. They consist of
cartilage, which has properties varying in a depth-specific manner, anchored to a porous
subchondral bone base. They are able to be stored between harvest and transplantation.
This dissertation presents strategies to address a subset of the remaining challenges of
reproducing these aspects in engineered grafts.
First, graft macrostructure was addressed by incorporating a porous base to gener-
ate biomimetic osteochondral grafts. Previous studies have shown advantages to using
porous metals as the bony base. Likewise, we confirmed that osteochondral constructs
can be cultured to robust tissue properties using porous titanium bases. The titanium
manufacturing method, selective laser melting, offers precise control, allowing for tailor-
ing of base shape and pore geometry for optimal cartilage growth and osteointegration.
In addition to viability studies, we investigated the influence of the porous base on the
measured mechanical properties of the construct’s gel region. Through measurements
and correlation analysis, we linked a decrease in measured mechanical properties to pore
area. We promote characterization of such parameters as an important consideration
for the generation of functional grafts using any porous base.
Next, we investigated a high intensity focused ultrasound (HIFU) denaturation of
gel-incorporated albumin as a strategy for inducing local tissue property changes in
constructs during in vitro growth. HIFU is a low cost, non-contact, non-invasive ul-
trasound modality that is used clinically and in the laboratory for such applications as
ablation of uterine fibroids and soft tissue tumors. Denaturing such proteins has been
shown to increase local stiffness. We displayed the ability incorporate albumin into tis-
sue engineering relevant hydrogels, alter transport properties, and visualize treatment
with its denaturation. HIFU treatment is aided by the porous metal base, allowing for
augmented heating. Though heating cartilage is used in the clinic, it is associated with
cell death. We investigated this effect, finding that the associated loss of viability re-
mains localized to the treatment zone over time. This promotes the option of balancing
desired changes in tissue properties against the concomitant cell viability loss.
In order to match clinically utilized allografts, engineered constructs must be scaled
up in size. This process is limited by diffusional transport of nutrients and other
chemical factors, leading to preferential extracellular matrix deposition in the con-
struct periphery. Many methods are being investigated for overcoming this limitation
in fixed-size constructs. In this chapter, we investigated a novel strategy in which small
constructs are cultured for future assembly. This modular assembly offers coverage of
variable sized defects with more consistent growth with more uniform distribution of
biochemical constituents than large constructs cultured on their own. Physiologic fail-
ure testing showed that integration of these tissues may be strengthened by increased
subunit strength or assembled culture. It is expected that bioadhesive caulking and/or
the incorporation of osteochondral bases would further increase integration of the as-
sembled large graft.
Finally, we sought to provide a preservation/storage protocol for engineered car-
tilage constructs. Such a technique is critical for clinical translation, providing the
engineered graft with a “shelf-life.” We adopted and evaluated the Missouri Osteo-
chondral Allograft Preservation System (MOPS), which had been shown to maintain
cell viability in native grafts for at least 63 days at room temperature without serum or
growth factors. Within the current clinical of 28 days, MOPS maintained chondrocyte
viability and 75% of the pre-preservation Young’s modulus without significant decline
in biochemical content, however it did not extend the clinical window as it had with
native grafts. Refrigeration with MOPS did not show any benefit at day 28, but proved
better with longer preservation times. These results are the first evaluating engineered
cartilage storage. Further optimization is necessary to extend storage tissue property
maintenance in storage.
Overall, this dissertation presents four strategies for increasing the translation po-
tential of engineered articular cartilage grafts by better matching the clinically utilized
native allograft system. Combining these techniques, one could ideally engineer small,
interlocking ostechondral constructs with HIFU modified interface properties, which
could be stored from maturity to implantation. Future optimization is required to bet-
ter understand and utilize these methods to engineer fully functional, clinically relevant
grafts.
Contents
List of Figures vii




1.1 Hypotheses and Specific Aims . . . . . . . . . . . . . . . . . . . . . . . 3
1.2 Significance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
1.3 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
1.3.1 Structure and Function of Articular Cartilage . . . . . . . . . . 14
1.3.2 Damage and Repair of Articular Cartilage . . . . . . . . . . . . 16
1.3.3 Tissue Engineering of Articular Cartilage . . . . . . . . . . . . . 21
1.3.3.1 The Scaffold . . . . . . . . . . . . . . . . . . . . . . . 21
1.3.3.2 The Cell Source . . . . . . . . . . . . . . . . . . . . . . 23
1.3.3.3 Applied Culture Factors . . . . . . . . . . . . . . . . . 24
i
2 Methods 26
2.1 Experimental Methods & Rationale . . . . . . . . . . . . . . . . . . . . 26
2.1.1 Fabrication of Cellular and Acellular 3D Constructs . . . . . . . 26
2.1.1.1 Tissue Harvest, Cell Isolation, and Expansion . . . . . 27
2.1.1.2 Fabrication of Cellular and Acellular Chondral-Only and
Osteochondral Constructs . . . . . . . . . . . . . . . . 28
2.1.2 Culture of Engineered Cartilage Tissue Constructs . . . . . . . 30
2.1.3 HIFU Setup . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
2.1.4 Preservation/Storage of Mature Constructs . . . . . . . . . . . . 31
2.1.5 Mechanical, Biochemical, & Histological Evaluation . . . . . . . 32
2.1.5.1 Spatially-Averaged Mechanical Properties . . . . . . . 32
2.1.5.2 Destructive Shear Testing . . . . . . . . . . . . . . . . 33
2.1.5.3 Depth-Dependent Mechanical Properties . . . . . . . . 34
2.1.5.4 Physiologic Failure Testing . . . . . . . . . . . . . . . 35
2.1.5.5 Biochemical Analysis . . . . . . . . . . . . . . . . . . . 36
2.1.5.6 Cell Viability and Metabolism . . . . . . . . . . . . . . 37
2.1.5.7 Histological Analysis . . . . . . . . . . . . . . . . . . . 38
2.1.6 Statistical Analyses . . . . . . . . . . . . . . . . . . . . . . . . . 38
3 Fabrication and Characterization of Tissue Engineered Osteochondral
Grafts 39
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.2 Fabrication and Structural Characterization of Porous Titanium Bases 41
3.2.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
ii
3.2.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
3.3 Mechanical Influence of Porous Base . . . . . . . . . . . . . . . . . . . 45
3.3.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
3.3.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
3.4 Fabrication, Culture, and Evaluation of Cell-Seeded OC constructs: Vi-
ability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
3.4.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
3.4.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
3.5 Fabrication, Culture, and Evaluation of Cell-Seeded OC constructs: Depth-
Dependent Mechanical Properties . . . . . . . . . . . . . . . . . . . . . 52
3.5.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
3.5.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
3.6 Evaluation of PCL as a Porous OC base . . . . . . . . . . . . . . . . . 56
3.6.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
3.6.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
3.7 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
3.8 Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
4 Focused Ultrasound Approach for Local Tissue Property Modulation 63
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
4.2 Spatiotemporal Control of HIFU/Power Optimization . . . . . . . . . . 66
4.2.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
4.2.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
4.3 Albumin Incorporation in Engineered Constructs . . . . . . . . . . . . 68
iii
4.3.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
4.3.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
4.4 Post-HIFU Effects on Solute Transport . . . . . . . . . . . . . . . . . . 70
4.4.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
4.4.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
4.5 Temperature Measurement During HIFU Application . . . . . . . . . . 71
4.5.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
4.5.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
4.6 Viability & Culture of Cell-Seeded Gel Constructs After HIFU Treatment 73
4.6.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
4.6.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
4.7 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
4.8 Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
5 Strategies for Scaling Up 79
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
5.2 A Concentric Circle Approach . . . . . . . . . . . . . . . . . . . . . . . 81
5.2.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
5.2.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
5.3 Engineering of Puzzle-shaped Grafts . . . . . . . . . . . . . . . . . . . 84
5.3.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
5.3.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
5.4 Assembly of Puzzle Shaped Grafts . . . . . . . . . . . . . . . . . . . . . 89
5.4.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
iv
5.4.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
5.5 Integration Techniques for Assembled Puzzle-Shaped Grafts . . . . . . 94
5.5.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
5.5.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
5.6 Evaluation of Biocompatibility . . . . . . . . . . . . . . . . . . . . . . . 96
5.6.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
5.6.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
5.7 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
5.8 Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
6 Preservation/Storage of Engineered Grafts 105
6.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
6.2 Preservation/Storage with MOPS . . . . . . . . . . . . . . . . . . . . . 107
6.2.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
6.2.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
6.3 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
6.4 Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
7 Conclusions & Future Directions 121
7.1 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
7.1.1 Fabrication and Characterization of Tissue Engineered Osteo-
chondral Grafts . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
7.1.2 Focused Ultrasound Approach for Local Tissue Property Modu-
lation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
v
7.1.3 Strategies for Scaling Up . . . . . . . . . . . . . . . . . . . . . . 123
7.1.4 Preservation/Storage of Engineered Grafts . . . . . . . . . . . . 123
7.2 Future Directions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
7.2.1 Fabrication and Characterization of Tissue Engineered Osteo-
chondral Grafts . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
7.2.2 Focused Ultrasound Approach for Local Tissue Property Modu-
lation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
7.2.3 Strategies for Scaling Up . . . . . . . . . . . . . . . . . . . . . . 127
7.2.4 Preservation/Storage of Engineered Grafts . . . . . . . . . . . . 128
7.3 Concluding Remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
Bibliography 133
Appendix 173
A Thesis Publications 173
A.1 Full Length Manuscripts . . . . . . . . . . . . . . . . . . . . . . . . . . 173
A.2 Technical Notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
A.3 Book Chapters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
A.4 Conference Abstracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
vi
List of Figures
1.1 Schematic of dissertation structure . . . . . . . . . . . . . . . . . . . . 2
1.2 Graphic representation of Hypothesis 1 . . . . . . . . . . . . . . . . . . 4
1.3 Graphic representation of Hypothesis 2 . . . . . . . . . . . . . . . . . . 6
1.4 Graphic representation of Hypothesis 3 . . . . . . . . . . . . . . . . . . 8
1.5 Graphic representation of Hypothesis 4 . . . . . . . . . . . . . . . . . . 9
1.6 Introduction to cartilage structure and function . . . . . . . . . . . . . 17
2.1 Schematic of high intensity focused ultrasound treatment . . . . . . . . 32
2.2 Spatially-averaged mechanical property testing . . . . . . . . . . . . . . 33
2.3 Schematic of destructive shear testing . . . . . . . . . . . . . . . . . . . 34
2.4 Depth-dependent mechanical property testing schematic . . . . . . . . 35
2.5 Schematic of physiologic failure testing . . . . . . . . . . . . . . . . . . 36
3.1 Stereoscopic images of regular orientation titanium bases . . . . . . . . 43
3.2 Stereoscopic images of random oriented titanium and tantalum bases . 47
3.3 “On top” testing schematic and results . . . . . . . . . . . . . . . . . . 49
3.4 Pore bulging effect . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
vii
3.5 OC tissue properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
3.6 OC viability and histology . . . . . . . . . . . . . . . . . . . . . . . . . 54
3.7 Depth-dependent properties of chondral-only and OC constructs . . . . 55
3.8 PCL OC viability and tissue properties . . . . . . . . . . . . . . . . . . 57
3.9 Schematic of multilayered titanium OC base . . . . . . . . . . . . . . . 61
4.1 Denaturation of albumin by high intensity focused ultrasound . . . . . 67
4.2 Unimpeded growth in constructs with incorporated albumin. . . . . . . 69
4.3 HIFU Transport effects and sterile application . . . . . . . . . . . . . . 71
4.4 Enhanced temperature elevations with incorporated base . . . . . . . . 72
4.5 Cell viability effects remain localized over time . . . . . . . . . . . . . . 75
5.1 Schematic of puzzle piece strategy. . . . . . . . . . . . . . . . . . . . . 81
5.2 Experimental design of concentric circle studies . . . . . . . . . . . . . 82
5.3 CC mechanical and viability results . . . . . . . . . . . . . . . . . . . . 85
5.4 CC histology and gross images . . . . . . . . . . . . . . . . . . . . . . . 86
5.5 Experimental flowchart . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
5.6 Puzzle strategy: effects of individual culture . . . . . . . . . . . . . . . 90
5.7 Results of puzzle assembly . . . . . . . . . . . . . . . . . . . . . . . . . 92
5.8 Results of puzzle assembly: viability and histology . . . . . . . . . . . . 93
5.9 Puzzle strategy integration techniques: failure testing . . . . . . . . . . 95
5.10 Puzzle strategy integration techniques: histology . . . . . . . . . . . . . 96
5.11 Evaluation of puzzle constructs in a nude mouse model . . . . . . . . . 97
viii
5.12 Demonstration of puzzle OC constructs; demonstration of in situ assem-
bly and trimming of puzzle constructs . . . . . . . . . . . . . . . . . . 102
6.1 Schematic of experimental group conditions for preservation studies . . 109
6.2 MOPS-25 preservation during 28-day clinical window . . . . . . . . . . 110
6.3 Preservation viability and metabolism during 28-day clinical window . . 111
6.4 Preservation (MOPS-25, MOPS-4, and Continued Culture scenarios) for
28-day clinical window . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
6.5 Extending the clinical window of preservation: properties at 56 days
preserved . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
6.6 Extending the clinical window of preservation: viability at 56 days pre-
served . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
7.1 Synthesis of studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
ix
List of Tables
3.1 OC base properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44





ACI autologous chondrocyte implantation
ANOVA analysis of variance










ETF energy to failure
EW egg white
EY equilibrium Young’s modulus
FBS fetal bovine serum
FGF fibroblast growth factor
G* dynamic modulus
GAG glycosaminoglycan
HIFU high intensity focused ultrasound
HSD honest significant difference
IGF insulin-like growth factor
ITS insulin-transferrin-selenium
MACI matrix-induced autologous chondrocyte implantation
MMP metalloproteinase
MOPS Missouri Osteochondral Allograft Preservation System
MSC mesenchymal stem cell
MTT 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide
xii









PDGF platelet derived growth factor
PG proteoglycan
SEM scanning electron microscopy
SLM selective laser melting






I would like to thank the National Institutes of Health (NIH) and Columbia Univer-
sity for funding my graduate research and allowing me to share my results through
publications and conference presentations.
I am extremely grateful for the guidance, support, and mentorship of my committee
members: Clark T. Hung, Ph.D., Elisa E. Konofagou, Ph.D., Gerard A. Ateshian,
Ph.D., James L. Cook, DVM, Ph.D., and Robert W. Klein, M.S. Working in Dr.
Konofagou’s laboratory in the summer of 2009 truly whet my interest in scientific
research, inspiring me to pursue graduate studies. Dr. Hung gave me the privilege of
translating that research experience to his laboratory. He has played a large role in
shaping my ability to approach scientific problems in a creative manner. Dr. Ateshian
has served as a secondary mentor, helping me to better design robust experiments
through insightful discussion. Dr. Cook and Robert Klein have also been instrumental
to my graduate work, helping me to add greater depth to my studies by incorporating
clinical and corporate facets.
I am thankful that my graduate work has been bolstered by collaboration. Chapter
3 describes research conducted as a collaboration with Stryker Orthopaedics. Chap-
xiv
ter 4 describes research conducted as a collaboration with Dr. Konofagou’s Ultrasound
Elasticity Imaging Laboratory. For these studies, I received guidance and aid from Car-
oline Maleke, Ph.D., Gary Hou, Ph.D., Yang Han, M.S., Shutao Wang, Ph.D., Julien
Grondin, Ph.D., and Fabrice Marquet, Ph.D. Chapter 5 describes a collaboration with
Dr. Ateshian’s Musculoskeletal Biomechanics Laboratory and Dr. Cook’s Comparative
Orthopaedic Laboratory. Chapter 6 describes a collaboration with Dr. Cook’s Compar-
ative Orthopaedic Laboratory. In additional studies, not included in this dissertation,
I collaborated with Dr. Gordana Vunjak-Novakovic (Laboratory for Stem Cells and
Tissue Engineering) and Dr. Eric Lima (The Cooper Union). Keith Yeager and Arthur
Autz provided help in fabricating multiple devices used in these studies, including the
ultrasound chamber (Chapter 4) and the custom punches (Chapter 5). To all of these
people, I am grateful.
I have also had the honor of mentoring orthopaedic surgeon residents, master’s, and
undergraduate students. Most predominantly, I would like to thank Stephanie Lee,
William Yu, Maria Georgescu, Reuben Saunders, Lily Rogers, and Katherine Wood,
each of whom aided my research for a year or more.
I’d like to express my gratitude to my friends and colleagues in the Cellular En-
gineering and Musculoskeletal Biomechanics Laboratories, including Grace O’Connell,
Ph.D., Elizabeth Oswald, Ph.D., Eric Lima, Ph.D., Terri-Ann Kelly, Ph.D., Andrea
Tan, Ph.D., Sonal Sampat, Ph.D. Elena Alegre-Aguaron, Ph.D., Michael Albro, Ph.D.,
Sevan Oungoulian, Ph.D., Brendan Roach, M.S., Eben Estell, M.S., Amy Silverstein,
M.S., Robert Stefani, M.S., Alexander Cigan, M.S., Robert Nims, M.S., Krista Durney,
M.S., Brian Jones, M.S., Chieh Hou, M.S., and Brandon Zimmerman.
xv
Lastly, I’d like to thank my family and friends for their support. My family has
always instilled in me the value of education. In particular, my grandparents have
always urged me to pursue medical research, especially in the area of whatever is ailing
them. I am immensely grateful to my parents and extended family for funding my
education over the years. I’d like to thank Talia for sticking by me through our long
distance relationship (there is no quick way to get to Midtown East). Many of my
family and friends have asked me what I have been doing in the lab for the past five




Damage to articular cartilage is particularly pernicious due to the tissue’s limited heal-
ing capacity. Current surgical repair strategies for large defects are hindered either by
graft supply or technique effectiveness. As an alternative, research efforts have aimed
to generate tissue engineered articular cartilage as a replacement tissue. While great
strides have been made in engineering these grafts, more work is required before transla-
tion into the clinic [Griffith and Naughton, 2002,Johnstone et al., 2013,Tan and Hung,
2011, Huey et al., 2012, Mauck and Burdick, 2011, Gadjanski and Vunjak-Novakovic,
2015,Jeon et al., 2014,OConnell et al., 2012,Johnson et al., 2010,Bertram et al., 2012].
The overarching motivation of the work described in this thesis is to address a subset
of these challenges, investigating strategies to increase the translational potential of
these engineered tissues by making them better mimic native grafts for success upon
in vivo implantation. Namely, the studies contained promote strategies for replicating
graft structure and architecture (incorporation of porous bases, ultrasonic alteration of
1
internal properties), scaling up graft size, and developing a preservation/storage proto-
col (Fig. 1.1). In order to investigate and understand such strategies, hypotheses and
specific aims are listed followed by the significance of this work. Background informa-
tion for this research is provided, focusing on articular cartilage, its injury, its clinical
repair strategies, and tissue engineering strategies. More specific background material
is provided in each chapter.
Figure 1.1: This dissertation consists of four strategies for increasing translational rel-
evance of engineered cartilage grafts. This schematic depicts these strategies applied
to a commonly used ˜4 mm, ˜2.3 mm thick chondral-only cylindrical graft. Chapter
3 describes incorporation of an osteochondral base. Chapter 4 describes the use of
high intensity focused ultrasound to alter internal tissue properties. Chapter 5 de-
scribes strategies for scaling up graft size. Chapter 6 describes the development of a
preservation/storage protocol for giving mature grafts a clinical “shelf-life.”
2
1.1 Hypotheses and Specific Aims
This research described in this dissertation is divided into four chapters, each describ-
ing a different strategy for increasing the translational potential of tissue engineered
grafts. Each strategy either utilizes osteochondral constructs or may be easily applied
to osteochondral constructs. To evaluate and understand these strategies, the following
hypotheses and specific aims were developed. The rationale for each hypothesis follows
its description.
Hypothesis 1: Chondrocyte-seeded hydrogels can be success-
fully cultured on porous titanium bases for tissue engineering
of biomimetic osteochondral constructs.
 Specific Aim 1a: Fabricate and characterize titanium osteochondral bases.
 Specific Aim 1b: Characterize the mechanical influence of the porous base.
 Specific Aim 1c: Culture osteochondral constructs on titanium bases.
 Specific Aim 1d: Investigate additional base materials, namely polycaprolactone
(PCL).
Previous research by Lima et al. promotes the use of porous metals over devitalized
trabecular bone as a base material for tissue engineered osteochondral constructs [Lima
et al., 2008a]. Our collaborators at Stryker Orthopaedics (Mahwah, NJ, USA) are able
to fabricate porous titanium bases through selective laser melting (SLM) [Mullen et al.,
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Figure 1.2: Graphic representation of Hypothesis 1 (Chapter 3).
2009,Mullen et al., 2010,Stamp et al., 2009], a material which is used clinically in tibial
trays and patellar components. This manufacturing technique offers the ability to select
pore size and strut orientation to optimize bone ingrowth [Kienapfel et al., 1999,Bobyn
et al., 1980, Bobyn et al., 1999a, Mullen et al., 2009, Nilles et al., 1973, Hulbert et al.,
1970, Assad et al., 2003]. These bases contain large pore sizes compared to Zimmer
Biomet’s tantalum trabecular metal (Warsaw, IN, USA), which may allow for increased
nutrient transport, yet may lead to gel deformation into these pores.
In Chapter 3, porous titanium bases are evaluated for their use in tissue engineered,
bilayered, biocomposite osteochondral constructs (Fig. 1.2). The influence of the pores
on the measured mechanical properties is identified and characterized. Additionally,
PCL is evaluated as an additional base material for osteochondral tissue engineering.
PCL is a biocompatible, biodegradable material, which has been used for other cartilage
tissue engineering applications [Lee et al., 2010, Moutos et al., 2010], but not yet as a
porous osteochondral base. In addition to using novel osteochondral base materials,
4
the studies described in this chapter promote consideration of the porous base as an
influencer of osteochondral construct mechanical properties, which may be applicable to
porous bases of other materials. The majority of the studies described in this chapter
has been published in Acta Biomaterialia [Nover et al., 2015c]. Related abstracts
include: [Nover et al., 2012b,Nover et al., 2012c,Nover et al., 2013].
Hypothesis 2: High Intensity Focused Ultrasound (HIFU) is a
feasible tool for precise, local alteration of tissue mechanical
properties.
 Specific Aim 2a: Investigate transport effects caused by HIFU with an egg white
albumin containing gel system.
 Specific Aim 2b: Investigate collateral cell viability effects caused by heating cel-
lular constructs.
 Specific Aim 2c: Investigate gel incorporable proteins, such as albumin, for via-
bility and changes in mechanical properties.
 Specific Aim 2c: Develop a method for sterile application of HIFU.
Spatial modulation of tissue properties during in vitro growth has not been previ-
ously described (Fig. 1.3). HIFU is used in the clinic and/or laboratory for minimally
or non-invasive surgical techniques such as lithotripsy [Yoshizawa et al., 2009, Ikeda
et al., 2006], ablation of uterine fibroids [Hesley et al., 2008, Stewart et al., 2003,Tem-
pany et al., 2003], and ablation of other soft tissue cancers [Fischer et al., 2010,Maleke
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Figure 1.3: Graphic representation of Hypothesis 2 (Chapter 4).
and Konofagou, 2008, Wu et al., 2003]. Heating of tissues or gels can induce local
stiffening through protein denaturation [Maleke and Konofagou, 2008, Shahmirzadi
et al., 2014, Nandlall et al., 2010, Lafon et al., 2005, Divkovic et al., 2007, Chen et al.,
2007, Iizuka et al., 1999, Takegami et al., 2004, Wu et al., 2001]. HIFU heating can be
controlled by varying the power, treatment duration, and focal position.
In Chapter 4, HIFU heating is explored as a tool for precise modulation of local
tissue properties. Here, HIFU is applied to small constructs that in culture increase
in stiffness over time; however, in all other common applications, HIFU is applied
to large, dense structures. As desired internal inhomogeneities, particularly stiffening,
may block transport and hinder growth if incorporated a priori, HIFU’s use may require
optimization of application.
Heating of cartilage is currently utilized clinically. Radiofrequency energy probes
are used as a minimally invasive method of debriding fibrillated cartilage surfaces and
annealing lesion edges [Uribe, 2003], yet the direct contact of the probe and tissue
leads to widespread cell death [Yasura et al., 2006, Shellock and Shields, 2000, Ryan
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et al., 2003, Good et al., 2009]. Lasers have been used to reshape cartilage [Protsenko
et al., 2008], but may lead to calcification of laser irradiated zones [Karam et al., 2006].
Compared to optical methods, HIFU offers better depth penetration since it is not
affected by tissue opacity.
This represents a novel adoption of HIFU technology for tissue engineering purposes.
The studies described in this chapter have been submitted to Medical Engineering &
Physics for review as a technical note [Nover et al., 2015a]. Related abstracts include:
[Konofagou et al., 2011,Nover et al., 2011a,Nover et al., 2014b,Nover et al., 2014a,Nover
et al., 2011b,Nover et al., 2011c,Nover et al., 2012a].
Hypothesis 3: Nutrient transport limitations in the tissue en-
gineering of large constructs can be overcome by engineering
smaller constructs for later assembly.
 Specific Aim 3a: Engineer and evaluate concentric rings of cartilage.
 Specific Aim 3b: Engineer and evaluate larger constructs assembled from small
interlocking puzzle-shaped tissue subunits.
Scaling up the size of engineered cartilage tissues remains a critical barrier for clinical
translation [Hung et al., 2003,Tan and Hung, 2011] (Fig. 1.4). It is important to achieve
the functional tissue properties as achieved with smaller tissues, since with larger grafts,
the applied loads may not be shouldered by surrounding tissue.
Tissue growth is limited by diffusion of nutrients and chemical factors. Fick’s law
states that diffusion time is proportional to the square of the distance [Atkins, 1994].
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Figure 1.4: Graphic representation of Hypothesis 3 (Chapter 5).
This limitation may be exacerbated by nutrient consumption [Buckley et al., 2009a]
and the density of the elaborated ECM in the diffusional pathway [Leddy et al., 2004].
Multiple strategies have been investigated for overcoming this limitation [Albro
et al., 2008, Bian et al., 2010a, Hung et al., 2004, Lima et al., 2007, Mauck et al., 2000,
Mauck et al., 2003b,Mauck et al., 2003c,Vunjak-Novakovic et al., 1999,Buckley et al.,
2009b, Mauck et al., 2003a, Albro et al., 2010, Davisson et al., 2002, Cigan et al., 2014,
Nims et al., 2015,Lima et al., 2012].
In Chapter 5, proof-of-principle studies are described for a novel approach in which
small subunits are cultured individually and then assembled after tissue growth. The
studies described in this chapter have been submitted to the Journal of Biomechanics
for review [Nover et al., 2015b]. Related abstracts include: [Nover et al., 2014e, Nover
et al., 2016].
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Hypothesis 4: The Missouri Osteochondral Allograft Preserva-
tion System (MOPS) can be used to preserve tissue engineered
constructs.
 Specific Aim 4a: Preserve tissue engineered cartilage with MOPS.
 Specific Aim 4b: Investigate the influence of temperature on MOPS and compare
to continued culture condition.
Figure 1.5: Graphic representation of Hypothesis 4 (Chapter 6).
Due to mandatory disease screening (˜14 days) and limited supply, native osteo-
chondral allografts are stored in a fetal bovine serum (FBS)-containing media in re-
frigeration [Sherman et al., 2014, Williams et al., 2004]. As graft success is seen as a
function of chondrocyte viability, surgeons consider 28 days post-harvest as the end
of the transplantation window [Bakay et al., 1998, Gross et al., 2008, Gross et al.,
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2005, Pallante et al., 2012]. Much ongoing research aims to expand the duration of
this window [Williams et al., 2004,Williams et al., 2007,Teng et al., 2008,Csönge et al.,
2002, Ball et al., 2004, Bian et al., 2010b, LaPrade et al., 2009]. Recently, Stoker et al.
developed a preservation/storage protocol (MOPS), which was shown to maintain day
0 chondrocyte viability for at least 63 days without serum, growth factors, or refriger-
ation [Cook et al., 2014b,Stoker et al., 2012].
We were motivated by these results to adopt and evaluate MOPS for tissue engi-
neered grafts (Fig. 1.5). Such a protocol is critical for translation of engineered cartilage
tissues to the clinic [Griffith and Naughton, 2002], giving the product a “shelf-life.”
In Chapter 6, we describe studies conducted to evaluate, understand, and optimize
preservation/storage of engineered cartilage grafts. These results are the first evaluating
engineered cartilage storage. The studies described in this chapter have been published
in the Journal of Orthopaedic Research [Nover et al., 2015e]. Related abstracts include:
[Nover et al., 2014c,Nover et al., 2015f,Nover et al., 2015d].
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1.2 Significance
Osteoarthritis (OA) and traumatic cartilage injury are common maladies, responsi-
ble for a significant economic burden [Leigh et al., 2001, Bitton, 2009, Helmick et al.,
2008,Kim, 2008,Lawrence et al., 2008,Flanigan et al., 2010]. Of the treatment options,
osteochondral allografts offer the best long-term treatment of large cartilage defects,
replacing degraded with healthy tissue, thus matching the native bone-cartilage archi-
tecture [Sherman et al., 2014, Gross et al., 1975, Gross et al., 2008, Gross et al., 2005].
Still, allografts are in short supply [Paige and Vacanti, 1995, Mow et al., 1991, Langer
and Vacanti, 1993]. As an effort to generate additional replacement tissues, our lab
and others have been investigating functional tissue engineering as a cell-based strat-
egy [Butler et al., 2000,Guilak et al., 2001].
Through application of physical and chemical stimuli [Butler et al., 2000, Guilak
et al., 2001], our lab has engineered small articular cartilage grafts using an agarose-
chondrocyte system with native or near-native mechanical and biochemical properties
[Mauck et al., 2000,Kelly et al., 2013]. However, our laboratory believes that successful
replication of native grafts in vitro will lead to success in vivo [Hung et al., 2004], and
much work is still required to truly achieve that goal.
This dissertation presents research concerning four strategies for potentially repro-
ducing the characteristics of native grafts in our engineered grafts. Along with evalua-
tion of these strategies, this dissertation describes techniques for better understanding
the nature of these engineered grafts.
Chapter 3 describes the incorporation of a porous base into the agarose-chondrocyte
system to engineer osteochondral grafts. Building on the work of Lima et al. [Lima
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et al., 2004, Lima et al., 2008a, Ng et al., 2010], this chapter predominantly evaluates
porous titanium for this application. The precise fabrication technique [Mullen et al.,
2009,Mullen et al., 2010,Stamp et al., 2009] used to generate these porous bases offers
the ability to potentially manufacture custom bases for other applications, such as
matching anatomic curvature [Roach et al., 2015] or larger anatomic shapes [Hung et al.,
2003], while optimizing pore parameters for nutrient transport and osteointegration
[Bobyn et al., 1980]. Here, we characterize pore structure and its influence on the
measured mechanical properties of the cell-seeded gel region, which may be applicable
to other porous bases used for this application. Interactions between the gel and the
underlying porous base may be more complex than previously assumed [Lima et al.,
2004]. Understanding these phenomena may be critical in generating functional grafts.
Chapter 4 describes the novel application of high intensity focused ultrasound for
thermally altering local properties within the engineered gel. Proof-of-principle studies
promote this technique as feasible, suggesting that it may be used for on-demand repro-
duction of such anatomic structures as a subchondral plate, the virtually impermeable
bone-cartilage interface critical for load-bearing and lubrication [Hwang et al., 2008].
This application is significant from a focused ultrasound standpoint as it represents a
shift from treating large, dense tissues to treating small tissues of low, yet increasing,
density.
Chapter 5 describes a novel strategy for overcoming diffusional limitations for en-
gineering large tissues by assembling smaller engineered tissues. This relatively simple
method may offer the ability to treat defects of variable size and may be utilized in con-
junction with other strategies, including dynamic loading [Mauck et al., 2000], nutrient
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channels [Bian et al., 2009a, Cigan et al., 2014], and others [Vunjak-Novakovic et al.,
1999, Lima et al., 2012, Roach et al., 2013]. In addition to proof-of-principle studies,
this chapter introduces physiologic failure testing for evaluating the functionality of the
engineered tissues.
Finally, Chapter 6 describes the first reported studies aiming to maintain engineered
cartilage properties during storage, providing them with a “shelf-life.” Such a technique
is critical to clinical translation. Currently allografts undergo storage between harvest
and implantation, allowing for disease screening and surgical logistics [Csönge et al.,
2002,Malinin et al., 2006,Pallante et al., 2012]. It is expected that a tissue engineered
graft would require a similar protocol.
These strategies represent steps forward toward clinical translation of functional
engineered osteochondral grafts. Each of these methods may be utilized independently,




1.3.1 Structure and Function of Articular Cartilage
The hyaline articular cartilage of the knee joint that lines the surfaces of the tibia, femur,
and patella is responsible for the joint’s load-bearing ability [Mow et al., 2005]. It is also
known for its superb friction, lubrication, and wear properties [Mow et al., 2005, Mow
et al., 1992]. It is a 0.5-7 mm thick shiny, white, avascular soft tissue predominantly
comprised of 68-85% water, 10-20% type II collagen per wet weight, 5-10% proteogly-
cans (PGs) per wet weight, and chondrocytes, the cells specific to cartilage (Fig. 1.6,
top-left) [Mow et al., 2005,Eyre, 1980,Muir et al., 1970,Stockwell, 1991,Buckwalter and
Rosenberg, 1982,Hardingham and Muir, 1974,Hardingham and Fosang, 1992,Ratcliffe
et al., 1984, Linn and Sokoloff, 1965, Torzilli, 1988, Mow et al., 1992, Lipshitz et al.,
1976, Eyre, 2002, Ateshian et al., 1991, Eckstein et al., 1996]. Additional collagens
types III, VI, IX, X, XI, XII, and XIV, proteins and lipids are also present at a minor
level [Eyre, 2002, Eyre, 1980, Mow et al., 2005]. PGs are large molecules consisting of
a core protein attached to at least one gylcosaminoglycan (GAG) chain [Buckwalter
et al., 2005,Mow et al., 2005]. The most prominent PG (80-90%) in articular cartilage
is aggrecan, yet other PGs include decorin, biglycan, and fibromodulin [Mow et al.,
2005, Buckwalter et al., 2005, Roughley and Lee, 1994]. The most common GAGs in
cartilage are hyaluronic acid, keratin sulfate, chondroitin sulfate, and dermatan sul-
fate [Buckwalter et al., 2005,Roughley and Lee, 1994]. The fixed charge density associ-
ated with GAGs results in a swelling pressure within the cartilage that is balanced by
the collagen network [Maroudas, 1976]. Articular cartilage’s tensile strength is tied to
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its collagen network and its compressive strength is tied to its PG content [Mow et al.,
2005].
Chondrocytes maintain cartilage tissues by synthesizing and degrading/remodeling
(via metalloproteinases, MMPs) extracellular matrix (ECM) [Guilak and Hung, 2005].
These cells comprise less than 10% of the volume of articular cartilage in adults [Stock-
well, 1979, Stockwell, 1991]. Cell density decreases with age [Jadin et al., 2005]. Cell
densities have been reported as 60-90×106 cells/mL in the calf femoropatellar groove
and 10-15×106 cells/mL in the adult femur [Stockwell, 1991].
Articular cartilage can be described as a biphasic material, consisting of a solid phase
(collagen, PGs, additional proteins, and chondrocytes) and a mobile fluid phase (water
and electrolytes) [Mow et al., 2005,Lai et al., 1991,Mow et al., 1980,Muir et al., 1970].
Separating the charged electrolytes into a third phase allows for an understanding of
cartilage swelling [Mow et al., 2005,Lai et al., 1991,Gu et al., 1993,Lai et al., 2000,Mow
et al., 1998].
The properties of articular cartilage vary through the depth of the tissue (Fig. 1.6,
center) [Mow et al., 2005,Buckwalter et al., 2005,Clarke, 1971,Guilak et al., 1995,Mow
and Wang, 1999, McDevitt, 1973, Schinagl et al., 1997]. The 10-20% closest to the
articular surface is known as the superficial tangential zone, which has high water and
collagen but low aggrecan content [Lipshitz et al., 1976,Mow et al., 2005]. In this zone,
collagen fibers are aligned parallel to the surface and chondrocytes are morphologically
flat [Clarke, 1971]. The next 40-60% is the middle zone, which contains the highest
concentration of aggrecan, but less collagen than the superficial zone [Lipshitz et al.,
1976, Mow et al., 2005, Ratcliffe et al., 1984]. The final 30% is known as the deep
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zone, which contains perpendicularly oriented collagen fibers, similar in quantity to
the middle zone. The deep zone connects to a layer of calcified cartilage abutting
subchondral bone at the tidemark [Clarke, 1971, Mow et al., 2005]. Water content
decreases from the superficial to deep zone [Mow et al., 2005]. The calcified cartilage
and underlying subchondral bone comprise the subchondral bone plate, a virtually
impermeable structure that allows for interstitial fluid pressurization, and thus load
bearing and lubrication (Fig. 1.6, bottom-right) [Hwang et al., 2008, Pan et al., 2009,
Park et al., 2003,Soltz and Ateshian, 1998].
In the joint, contact stresses usually range from 1-6 MPa in situations of light to
moderate activity [Brown and Shaw, 1983, Ahmed and Burke, 1983]. Under strenuous
activity, contact stresses have been calculated to reach 12 MPa [Matthews et al., 1977].
Cartilage displays tension-compression nonlinearity with an equilibrium compressive
modulus of 0.2-1.4 MPa and an equilibrium tensile modulus of 1-30 MPa [Mauck and
Burdick, 2011,Ateshian and Hung, 2005,Wang et al., 2002,Akizuki et al., 1986].
1.3.2 Damage and Repair of Articular Cartilage
Articular cartilage has limited regenerative capacity due to its avascular and hypocel-
lular nature. Mainly, damage is due to OA or acute injury (i.e. degenerative lesions or
focal lesions [Falah et al., 2010]).
OA is the most common joint disease, particularly afflicting the middle aged and
elderly population [Buckwalter and Martin, 2006,Brooks, 2002,Leigh et al., 2001,Buck-
walter and Lappin, 2000]. OA is defined by a progressive degradation of the articu-
lar cartilage coupled with a poor attempt to repair that damage, causing remodeling
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Figure 1.6: Introduction to cartilage structure and function: (top-left) cartilage ECM
components (adapted from [Mow et al., 1992, Mow et al., 2005]); (center) zonal orga-
nization of cartilage (adapted from [Mow et al., 1992,Mow et al., 2005]); and (bottom-
right) joint loading (bold arrow indicates direction of load) leading to interstitial fluid
pressurization (thin arrows indicate fluid flow) due to subchondral bone plate (adapted
from [Hwang et al., 2008]).
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and sclerosis of the subchondral bone as well as formation of osteophytes [Buckwalter
et al., 2005, Buckwalter and Martin, 2006, Buckwalter and Mankin, 1997]. This leads
to the loss of normal structure and function [Buckwalter et al., 2005, Sherman et al.,
2014, Stockwell, 1991, Buckwalter and Martin, 2006]. Diagnosis of OA requires symp-
toms such as joint pain, restriction of motion, motion-associated crepitus, joint effusions,
and deformity [Buckwalter et al., 2005]. OA is more common in women than men, and
is prevalent worldwide [Buckwalter and Martin, 2006, Buckwalter and Lappin, 2000].
Nearly 27 million Americans suffer from OA, leading to an annual estimated economic
burden of $89.1 billion [Bitton, 2009, Helmick et al., 2008, Lawrence et al., 2008, Leigh
et al., 2001,Kim, 2008].
OA is classified as either primary or secondary. In primary (also known as idiopathic)
OA, the disease develops without known cause [Buckwalter et al., 2005,Buckwalter and
Martin, 2006]. In secondary OA, the disease develops following joint injury, infection,
another disorder [Buckwalter et al., 2005, Buckwalter and Martin, 2006]. Currently,
there is no treatment to prevent or cure OA and symptomatic treatments are often
unsatisfactory [Buckwalter and Martin, 2006].
Focal defects in articular cartilage due to acute traumatic injury are common and,
if untreated, may lead to secondary OA [Buckwalter and Mankin, 1998, Cole et al.,
2009]. A systematic review found full-thickness defects in 36% of athletes [Flanigan
et al., 2010]. In addition to physical injury, one can also suffer iatrogenic injury from
such procedures as graft harvesting [Tan and Hung, 2011]. Cell death stemming from
mechanotransduction following injury can result in chondrocyte death as early as a few
hours and as late as seven days after injury [Chen et al., 2001]. The natural attempt to
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repair the injury often leads to development of fibrocartilage, which lacks the mechanical
integrity of true cartilage and often degrades, leading to OA [Falah et al., 2010,Willers
et al., 2003].
If the cartilage loss is widespread, a total knee replacement, using metal implants
to replace the cartilage and underlying bone, is the common treatment. Unfortunately,
total knee replacements often require revision surgeries to correct the effects of wear,
subsidence, and loosening [Tan and Hung, 2011, Ayers, 1997, Whiteside, 1989, Bradley
et al., 1993, Mowery et al., 1987, Langer and Vacanti, 1993]. Artificial prostheses such
as these lack the ability to adapt to the joint environment in the same way as cartilage
[Mow et al., 1992]. This treatment is generally used in older patients with less active
lifestyles [Sperling et al., 1998].
There are multiple treatments available for focal and superficial defects (reviewed
in: [Günther, 2001,Falah et al., 2010,Cole et al., 2009,Makris et al., 2014,Willers et al.,
2003]). The prescribed treatment should be based on the patient-specific and defect-
specific factors [Cole et al., 2009]. Patient-specific factors include age, body mass index,
symptoms, commitments to occupation and family, risk-aversion, and responsiveness
and rehabilitation after prior treatment [Cole et al., 2009]. Defect-specific variables
include location, number, size, depth, geometry, containment, and joint condition [Cole
et al., 2009]. Depending on these factors, treatment options include but are not limited
to: debridement, microfracture [Goyal et al., 2013, Ulstein et al., 2014], enzymatic
treatments [Caplan et al., 1997], tissue adhesives [Ahsan et al., 1999, Harper, 1988],
laser welding/reshaping [Züger et al., 2001, Karam et al., 2006], radiofrequency [Ryan
et al., 2003, Shellock and Shields, 2000, Yasura et al., 2006, Uribe, 2003, Good et al.,
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2009], autologous chondrocyte implantation (ACI) [Brittberg et al., 1996,Harris et al.,
2010, Stein et al., 2012, Mandelbaum et al., 2007, Whittaker et al., 2005, Ulstein et al.,
2014], matrix-induced ACI (MACI) [Bartlett et al., 2005], autologous cell or tissue
periosteal grafts [O’Driscoll et al., 1986], osteochondral (OC) autografts with or without
mosaicplasty [Hangody et al., 1997, Robert, 2011, Hangody et al., 2001, Hangody and
Füles, 2003, Hangody et al., 2010, Filardo et al., 2015], and osteochondral allografts
[Gross et al., 2005, Sherman et al., 2014, Gross et al., 1975, Görtz and Bugbee, 2006,
De Caro et al., 2015].
For large (>2-3 cm2) focal defects, OC allografts are the most common repair tech-
nique [Sherman et al., 2014,De Caro et al., 2015] in the US. OC allografts are the only
truly biomimetic technique for restoring tissue organization [Gross et al., 1975, Sher-
man et al., 2014, Görtz and Bugbee, 2006]. Allografting has been shown to provide a
successful clinical outcome for over 30 years [Gross et al., 2005]. It is preferred over ACI
and autografts, which are associated with donor-site morbidity [Lee et al., 2000,Reddy
et al., 2007,Whittaker et al., 2005,Gilbert, 1997]. Also, ACI requires multiple surgeries,
is costly, and is more effective for young, active patients [Sherman et al., 2014,Ng et al.,
2010,Reddy et al., 2007,Whittaker et al., 2005,Mandelbaum et al., 2007]. Additionally,
consistently successful outcomes with osteochondral autografts are limited to young
patients with relatively small (<2 cm2) defects. Despite the success of OC allografts,
their supply is limited [Paige and Vacanti, 1995,Mow et al., 1991,Langer and Vacanti,
1993].
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1.3.3 Tissue Engineering of Articular Cartilage
With demand of OC allografts greatly outweighing the supply, there exists a need for
an alternative graft source. Functional tissue engineering [Butler et al., 2000, Langer
and Vacanti, 1993,Guilak et al., 2001] may provide a cell-based strategy for generating
additional replacement tissues [Lima et al., 2008a].
The goal of functional tissue engineering of cartilage is to place isolated cells in a
scaffold and provide exogenous factors, such as chemical and mechanical stimuli, to
generate tissues that can support in vivo loads [Butler et al., 2000,Guilak et al., 2001].
Our lab aims to culture grafts in vitro until they mimic native cartilage’s mechani-
cal, biochemical, and structural properties believing that this will lead to long-term in
vivo success [Hung et al., 2004, Jin et al., 2011]. Choice of cells, scaffold, and exoge-
nous factors influence the resulting engineered tissue product. The studies described
in this dissertation make use of chondrocytes encapsulated in agarose, a system that
has provided robust and repeatable ability to generate functional engineered articular
cartilage [Ng et al., 2010,Kelly et al., 2013,O’Connell et al., 2014].
1.3.3.1 The Scaffold
Due to their high water content and hydrophilic properties (similar to hydrated soft
tissues), hydrogels are a popular scaffold for cartilage tissue engineering [Smetana,
1993, Nguyen and West, 2002]. Our lab predominantly utilizes agarose as a tissue
engineering scaffold. Other hydrogel scaffolds in use for tissue engineering articular
cartilage include polyethylene glycol [Rice et al., 2008,Elisseeff et al., 2000], silk [Chao
et al., 2010,Yodmuang et al., 2015], hyaluronic acid [Burdick et al., 2005], collagen [van
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Susante et al., 1995], and alginate [van Susante et al., 1995].
Agarose is an uncharged, hydrophilic, non-degradable, biocompatible, thermore-
versible hydrogel derived from red seaweed [Roach et al., 2016, Benya and Shaffer,
1982, Aymard et al., 2001], which can be cast or three-dimensional (3D) printed into
complex shapes and maintain its form [Hung et al., 2003, Campos et al., 2013]. It is
a linear polysaccharide polymer that forms agar with agaropectin [Roach et al., 2016].
Outside of tissue engineering, it is commonly used in gel electrophoresis [Hammarlund
and Rising, 1953, Serwer, 1983, Hirschfeld, 1959, Bird and Jackson, 1959, Beaven and
Gratzer, 1959, Uriel, 1960, Matson, 1962]. Most importantly for cartilage tissue engi-
neering purposes, agarose allows for the encapsulation of chondrocytes in 3D culture
without loss of phenotype or morphology [Buschmann et al., 1992, Buschmann et al.,
1995,Benya and Shaffer, 1982,Lee and Bader, 1995,Lee and Bader, 1997]. Additionally,
agarose hydrogels display strain-dependent hydraulic permeability allowing for intersti-
tial fluid pressurization similar to cartilage [Mauck et al., 2000,Gu et al., 2003].
Agarose’s interrelated properties of gel concentration, pore size, and mechanical
properties (pore size and diffusivity are inversely related to concentration and stiffness)
can be fine-tuned for tissue engineering applications [Pernodet et al., 1997, Maaloum
et al., 1998,Ng et al., 2005,Scandiucci de Freitas et al., 2006,Albro et al., 2009,Mauck
et al., 2000, Gu et al., 2003]. Additionally, the gel’s stiffness is related to its thermal
history (i.e. its temperatures of gelation, storage, and mechanical testing) [Aymard
et al., 2001,Buckley et al., 2009b]. These factors allow for regulation of solute transport
in agarose gels fabricated for tissue engineering by choosing the agarose concentration,
so to entrap cell elaborated ECM, yet allow import of nutrients and export of cellular
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waste products [Roach et al., 2016]. With this in mind, our lab has repeatedly utilized
2% weight/volume (w/v) agarose for engineering articular cartilage with mechanically
functional properties [Ng et al., 2005,Ng et al., 2010,Hung et al., 2004].
Chondrocyte-seeded agarose has been implanted in vivo without graft-host rejection,
showing maintenance of the chondrogenic phenotype in vivo [Rahfoth et al., 1998, Ng
et al., 2010, Cook et al., 2003]. Agarose is currently in clinical trials in Europe as a
co-polymer with alginate in the Cartipatch system [Selmi et al., 2008].
1.3.3.2 The Cell Source
The studies in this dissertation solely use chondrocytes as a cell source for engineering
articular cartilage. Besides chondrocytes, others have also utilized mesenchymal stem
cells (MSCs) derived from bone marrow, [Ronziere et al., 2009, Moutos et al., 2010,
Huang et al., 2009, Buxton et al., 2010, Schulz et al., 2007], adipose tissue [Ronziere
et al., 2009, Valonen et al., 2010], and synovium [Sampat et al., 2011, Sampat et al.,
2013,Alegre-Aguarón et al., 2014,Gong et al., 2010,Pei et al., 2008a,Pei et al., 2008b]
for this purpose. However, as chondrocytes are already differentiated as cartilage cells,
they show a distinct advantage over MSCs in cartilage tissue engineering [Vinardell
et al., 2011,Erickson et al., 2008].
In this dissertation, studies utilize either juvenile bovine or adult canine chondro-
cytes, both of which have been shown to yield engineered cartilage with native or
near-native tissue properties [Ng et al., 2010,Mauck et al., 2000,Kelly et al., 2013,Bian
et al., 2010a].
Juvenile chondrocytes show greater biosynthetic capability than adult chondrocytes
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[Tew et al., 2001, Tran-Khanh et al., 2005, Adkisson et al., 2010]. Tissue engineering
with juvenile bovine chondrocytes has shown benefits of temporally applying of chemical
and/or physical factors in vitro [Byers et al., 2008,Martin et al., 2000,Lima et al., 2007].
As clinical acquisition of juvenile chondrocytes may be difficult, their clinical relevance
is also limited.
Adult chondrocytes may be acquired from healthy, non-load bearing cartilage though
this procedure is associated with donor site morbidity [Gilbert, 1997, Lee et al., 2000,
Reddy et al., 2007]. Alternatively, chondrocytes can be obtained from the afflicted
knee during debridement though cells isolated from OA tissue have been shown to
have reduced biosynthetic capability [Wang et al., 2003b,Günther, 2001,Bulstra et al.,
1989, Guerne et al., 1995, Evans and Georgescu, 1983]. Either scenario leads to an
insufficient number of acquired cells [Barbero et al., 2004, Bobacz et al., 2004]. This
challenge may be overcome by expanding allogenic cells, implantation of which exploits
the immunoprivileged quality of articular cartilage similar to OC allografts [Langer and
Gross, 1974]. Expansion of chondrocytes through passaging with appropriate growth
factors has been shown to maintain and enhance the chondrogenic phenotype leading
to active biosynthesis of ECM once encapsulated in agarose [Ng et al., 2010, Franci-
oli et al., 2007]. Without this system, plated chondrocytes dedifferentiate [Benya and
Shaffer, 1982].
1.3.3.3 Applied Culture Factors
Functional tissue engineering promotes the use of physiologically relevant physical stim-
uli for enhancing tissue growth [Hung et al., 2004, Butler et al., 2000]. For cartilage,
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such stimuli include deformational loading, osmotic loading, hydrostatic loading, and
electrokinetic phenomena [Tan and Hung, 2011, Guilak and Hung, 2005]. In the past,
rotating wall bioreactors were used to grow cartilage-like tissue; however this did not
match the physiologic physical environment of the native joint [Gooch et al., 2001,Kay-
sen et al., 1999, Vunjak-Novakovic et al., 1999, Freed et al., 1997, Obradovic et al.,
1999]. Physiologic loading such as hydrostatic pressure/perfusion loading [Carver and
Heath, 1999] or dynamic deformational loading [Mauck et al., 2000,Mauck et al., 2002],
has yielded robust results. Dynamic deformational loading enhances nutrient convec-
tion and mechanotransduction, mimicking native cartilage loading in the joint [Albro
et al., 2008, Mauck et al., 2003b, Mauck et al., 2003a, Chahine et al., 2009, Kim et al.,
1995,Mauck et al., 2000,Mauck et al., 2002].
Chemical factors have also been added to the in vitro culture environment to en-
hance tissue growth, including growth factors, such as transforming growth factor
(TGF)-β3, TGF-β1, insulin-like growth factor (IGF), fibroblast growth factor (FGF)-
2; corticosteroids, such as dexamethasone; and interleukins [Byers et al., 2008, Mauck
et al., 2003c, Bian et al., 2010b, Awad et al., 2003, Aydelotte et al., 1992, Lima et al.,




2.1 Experimental Methods & Rationale
In this chapter, general experimental methods are described and rationalized. Each
method is utilized by one or more of the studies described in this dissertation. In
the research chapters, the specific use of each technique, any deviations from these
descriptions, and any additional methods are outlined.
2.1.1 Fabrication of Cellular and Acellular 3D Constructs
The following procedure has been frequently utilized to acquire bovine and canine
chondrocyte to yield functional engineered cartilage once encapsulated in 3D [Ng et al.,
2010,Kelly et al., 2013,O’Connell et al., 2014].
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2.1.1.1 Tissue Harvest, Cell Isolation, and Expansion
Full depth articular cartilage was harvested from the femoral heads, tibial plateau, and
patellar groove of juvenile (4-6 week old) bovine knees (Green Village Packing, Green
Village, NJ, USA) or adult canine knees (donated by the Comparative Orthopaedic
Laboratory, University of Missouri, MO, USA) (n ≥ 2 per experiment). Tissues were
digested in buffered high-glucose Dulbecco’s Modified Eagle’s Medium (DMEM, Invit-
rogen, Carlsbad, CA, USA) containing 5% volume/volume (v/v) FBS (Altlanta Biolog-
icals, Norcross, GA, USA), 25 mM TES (Sigma-Aldrich, St. Louis, MO, USA), 25 mM
BES (Sigma-Aldrich), 2% v/v Minimum Essential Amino Acids (Sigma-Aldrich), 1%
v/v HEPES (Sigma-Aldrich), 1% v/v sodium bicarbonate (Sigma-Aldrich), 1% antibi-
otics/antimycotics (containing 10,000 units/mL penicillin, 10,000 μg/mL streptomycin,
and 25 μg/mL Fungizone® i.e. amphotericin B, Invitrogen), and 390 U/mL colla-
genase type IV or II (Worthington, Lakewood, NJ, USA) on an orbital shaker at 37
◦C. Digestions were performed until tissues were ˜50% digested (typically 11 hours for
juvenile bovine tissue and 8 hours for adult canine tissue). Following digestion, the
cell suspension was filtered through a 70 µm porous mesh, then sedimented with a
centrifuge for 15 minutes at 1500g. Chondrocytes were counted with a hemacytometer
and trypan blue.
Chondrocytes were plated (two-dimensional, 2D, culture) in tissue-culture treated
flasks or plates at 2.2×104 cells/cm2 in DMEM containing 10% v/v FBS, 1% antibi-
otics/antimycotics, and a growth factor cocktail consisting of 1 ng/mL TGF-β1 (Invit-
rogen), 5 ng/mL FGF-2 (Invitrogen), and optionally 10 ng/mL platelet derived growth
factor (PDGF)-ββ (Invitrogen). Cells were expanded to passage 1 (P1) or passage 2
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(P2). This protocol was adapted from Francioli et al. and has been shown to maintain
chondrogenic phenotype [Francioli et al., 2007,Ng et al., 2010,O’Connell et al., 2014].
The immature bovine model allows for an easier, more reliable, less financially ex-
pensive tissue growth, since the young chondrocytes have a high biosynthetic capability
as compared to adult [Tran-Khanh et al., 2005] and prefer a transient application of
growth factors in culture [Byers et al., 2008, Byers et al., 2006]; however, this model
is not clinically ideal. In the clinic, juvenile tissue is not easily acquired. If cells are
expected to be autogenic, most cells will stem from adults [Tan and Hung, 2011]. Ad-
ditionally, the bovine gait does not mirror that of humans and in vivo studies are not
easily performed.z
The adult canine model represents a clinical step forward toward the human model.
The anatomy, physiology, and biomechanics of the canine patellofemoral joint is similar
to that of humans, and there is a great amount of canine data previously reported [Ng
et al., 2010,Gregory et al., 2012,Ahern et al., 2009,Cook et al., 2014a]. Canines allow
for surgery, postoperative management, and comprehensive assessment, since they are
large enough to undergo arthroscopy and MRI, making the canine model an excellent
in vivo preclinical transplantation model [Ng et al., 2010, Gregory et al., 2012, Ahern
et al., 2009,Cook et al., 2014a].
2.1.1.2 Fabrication of Cellular and Acellular Chondral-Only and Osteo-
chondral Constructs
Chondrocytes were cast to a final cell density of 30×106 cells /mL in 2% w/v Type VII
(Sigma-Aldrich) by mixing equal volumes 60×106 cells/mL cell solution and 4% w/v
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agarose at ˜40
◦C as previously described [Kelly et al., 2006]. For HIFU experiments
utilizing egg white (EW) albumin, equal volumes of 120×106cells/mL cell solution
and EW were mixed, and then equal volumes of the resulting solution was mixed
with 4% w/v agarose to achieve the same final cell and agarose concentrations with
incorporated EW. In all acellular experiments, phosphate buffered saline (PBS) will be
used in the aforementioned casting process in the place of the cell solution or agarose
will be produced initially to the specified concentration. In all cases, agarose gel was
produced by mixing agarose powder with PBS, and then heating and sterilizing in an
autoclave at 121 ◦C for 25-30 min.
For fabrication of chondral-only constructs, the gel was cast between two glass panes,
and then the resulting slabs were punched into disks using dermal biopsy punches or into
other shapes using custom fabricated punches. Unless otherwise noted, final chondral-
only construct dimension was 4 mm diameter and 2.3 mm thickness. For the fabrication
of osteochondral constructs, the gel was placed into wells, and the base was press-fit
into the well, prevented from full insertion by an inner lip or a rubber stopper.
The agarose scaffold has been shown to prevent phenotype dedifferentiation [Benya
and Shaffer, 1982], and is currently used as a co-polymer with alginate in the Cartipatch
cartilage repair product, which is currently in clinical trials in Europe [Selmi et al.,
2008].
Albumin from bovine serum (BSA) or egg white is commonly used in gel phan-
toms for tissue ablation studies via thermal treatment methods [Chen et al., 2007, Di-
vkovic et al., 2007, Iizuka et al., 1999, Takegami et al., 2004, Hynynen, 1990]. It coag-
ulates at 67±1 ◦C via intermolecular β-sheet formation, changing color from clear to
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opaque white, allowing for easy visualization of the thermally-treated region [Divkovic
et al., 2007, Nandlall et al., 2010]. Albumin has also been utilized as a biological sol-
der [Noguera et al., 2007]. Albumin is the main protein component of the synovial fluid,
making it relevant to cartilage [Hui et al., 2012].
2.1.2 Culture of Engineered Cartilage Tissue Constructs
Constructs were cultured in chemically-defined, chondrogenic medium (CM) consisting
of high glucose DMEM supplemented with 1% v/v ITS (insulin-transferrin-selenium)+
premix (BD Biosciences, San Jose, CA, USA), 100 nM dexamethasone (Sigma-Aldrich),
1% antibiotics/antimycotics (Invitrogen), 50 μg/mL L-proline (Sigma-Aldrich), 100
μg/mL sodium pyruvate (Sigma-Aldrich), and 50 μg/mL ascorbic acid (Sigma-Aldrich)
as reported previously [Tan et al., 2010, Kelly et al., 2013]. TGF-β3 (R&D Systems,
Minneapolis, MN, USA) was supplemented throughout culture for constructs contain-
ing adult cells and for the first 14 days of culture for constructs containing juvenile
cells [Ng et al., 2010,Bian et al., 2007,Nover et al., 2014d,Ng et al., 2011,Byers et al.,
2008,Byers et al., 2006]. Medium was replaced three times per week. Medium provided
was scaled from the value of ˜1 mL per 4 mm diameter, 2.34 mm thickness construct
containing 30×106 cells/mL.
2.1.3 HIFU Setup
HIFU treatment was conducted according to [Maleke and Konofagou, 2008], utiliz-
ing a setup conducive to later incorporation of Harmonic Motion Imaging (HMI), an
ultrasound-based method of monitoring elastographic changes in tissues [Maleke and
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Konofagou, 2008,Maleke et al., 2005,Maleke and Konofagou, 2006,Maleke et al., 2006].
Briefly, this setup consists of an imaging transducer centrally positioned inside a confo-
cal therapeutic transducer (Fig. 2.1) and attached to a computer-controlled positioner
(Velmex Inc. Bloomfield, NY, USA). The two transducers were self-contained by at-
taching to a coupling cone containing degassed, distilled water and sealed with an
acoustically transparent latex membrane [Choi et al., 2010, Hou et al., 2014], which
allows the membrane to be coupled to the sample through degassed culture media,
PBS, water, or ultrasound gel. For imaging, a 7.5 MHz single-element pulse-echo trans-
ducer (Panametrics, Waltham, MA, USA) connected to a pulser/receiver (Panametrics
5051PR or Olympus 5072PR, Waltham, MA, USA) was used to target and monitor
treatment produced by the therapeutic transducer. For thermal treatment, either a
4.755 MHz (Riverside Research Institute, New York, NY, USA) or a 4.5 MHz (Ima-
sonics, Besancon, France) therapeutic transducer was used. Heating parameters vary;
these parameters represent an aspect of this treatment which will require further opti-
mization. Two function generators (Agilent (HP) 33120A and 33220A, Palo Alto, CA,
USA) were used to drive the therapeutic transducer with an an amplitude-modulated
waveform combining sine waves: one of the therapeutic transducer’s excitation fre-
quency at a varied amplitude with a 25 Hz wave of 5.086 Vpeak-to-peak amplitude. The
signal was amplified 50 dB with a power amplifier (Model 3000L, ENI®, NY, USA).
2.1.4 Preservation/Storage of Mature Constructs
Constructs were placed into sealed individual tubes with 1 mL of media per construct.
Tubes were shielded from light throughout preservation. Medium was changed every
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Figure 2.1: Schematic of high intensity focused ultrasound treatment of osteochondral
interface.
7 days. Constructs preserved by MOPS were stored at 25 ◦C with MOPS medium,
a proprietary formula that contains DMEM, antibiotics/antimycotics, dexamethasone,
ascorbic acid, L-glutamine, sodium pyruvate, insulin, transferrin, and selenous acid
[Cook et al., 2014b,Stoker et al., 2012].
2.1.5 Mechanical, Biochemical, & Histological Evaluation
2.1.5.1 Spatially-Averaged Mechanical Properties
Spatially-averaged mechanical properties were evaluated using a custom testing device
[Soltz and Ateshian, 1998](Fig. 2.2). Specimens were equilibrated in creep under a tare
load. After creep, a stress relaxation test was performed, consisting of a 10% strain
achieved in 200 s followed by relaxation. The load data during relaxation were fit to a
power curve to acquire the equilibrium load. From this equilibrium force, the applied
strain, and the construct’s cross-sectional area, the equilibrium Young’s modulus (EY)
was calculated. The dynamic modulus (G*) was evaluated at 0.01 Hz and 1% sinusoidal
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strain amplitude, superimposed over the steady-state response under 10% compressive
strain. Data were processed with a custom MATLAB (Mathworks, Natick, MA, USA).
EY is a measure of material stiffness. G* is better measure of functionality than EY
as cartilage’s is naturally dynamically loaded under physiologic conditions [Park et al.,
2004].
Figure 2.2: Spatially-averaged mechanical property testing setup.
2.1.5.2 Destructive Shear Testing
To assess the integration strength of OC constructs, half of the construct’s chondral
region was removed with a razor blade. The construct was then clamped in a custom
device and aligned with the exposed cross-section parallel to the mechanical tester’s
impermeable platen (Fig. 2.3). A 10 μm/s linear displacement was applied on the
exposed cross-section while the load was measured [Lima et al., 2008a]. The peak load
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was reported as the maximum load prior to failure, the shear stiffness was reported as
the curve-fit slope of the linear region of the force-displacement curve, and the energy
to failure (ETF) was reported as the integrated area under the force-displacement curve
up to the failure point, normalized to the interface area [Broom et al., 1996,Allan et al.,
2007,Lima et al., 2008a].
Figure 2.3: Annotated photo of shear testing apparatus with gel contrast enhanced in
blue for visualization.
2.1.5.3 Depth-Dependent Mechanical Properties
Half constructs were stained with LIVE/DEAD® Assay Kit (Invitrogen) for contrast,
placed in a custom microscope mounted device, and imaged (cross-section) at 10%
compressive strain [Kelly et al., 2006, Wang et al., 2003a] (Fig. 2.4). Images were
analyzed using texture correlation (Vic-2D, Correlated Solutions, Columbia, SC, USA)
to acquire local strains.
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Figure 2.4: Depth-dependent mechanical property testing schematic (Adapted from
[Wang et al., 2002]).
2.1.5.4 Physiologic Failure Testing
Constructs were evaluated for functionality by using compression to failure at 0.3%
of the construct thickness per second (0.3% strain/s at the center point) [Tan et al.,
2010] using a 50.8 diameter planar end, 32.5 mm radius convex surface plano-convex
lens (Newport Corporation, Irvine, CA, USA) within a tabletop material testing device
(Instron, Norwood, MA, USA, Fig. 2.5A). This novel testing configuration was selected
to simulate physiological compression between congruent articular surfaces, as the lens
would contact nearly the entire surface area of the construct when its apex penetrated
halfway through the construct thickness. The ETF was calculated using a custom
MATLAB program to integrate the area under the load-displacement curve from start
to failure (Fig. 2.5B), which was then normalized by tissue volume.
The failure response of the construct was visualized using a custom holding de-
vice was affixed to the Instron, consisting of an elevated reservoir with a transparent
base that allowed sample imaging via a right angle prism. Failure tests were recorded
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using a Grasshopper2 camera (Point Grey Research, Richmond, Canada) controlled
by the open-source µManager acquisition software (https://micro-manager.org/) to
capture images at 1 frame/s [Edelstein et al., 2010, Edelstein et al., 2014]. For visual-
ization, constructs were speckled with Verhoeff’s stain using an airbrush.
Figure 2.5: (A) Annotated photo of physiologic failure testing apparatus. Inset: A
plano-convex lens (blue) is attached to the loading platen (gray). A 16 mm width,
3 mm thick square construct is shown below the lens (pink). (B) Example of load-
displacement curve with ETF demarcated in blue.
2.1.5.5 Biochemical Analysis
Samples were weighed wet (WW), lyophilized, and then weighed dry (DW). Dried sam-
ples were digested in 0.5 mg/mL proteinase K (MP Biomedicals, Santa Ana, CA, USA)
in 50 nM Tris buffered saline with 1 mM EDTA (Sigma-Aldrich), 1 mM iodoacetamide
(Acros Organics, Geel, Belgium), and 10 μg/mL pepstatin A (Thermo Fisher Scientific,
Waltham, MA, USA) for 16 h at 56 ◦C [Kelly et al., 2006]. Either half or whole samples
were utilized for biochemical analysis.
Deoxyribonucleic acid (DNA) content was assessed using a PicoGreen double-stranded
DNA kit (Invitrogen) adapted for microtiter plates with lambda phage DNA stan-
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dards [McGowan et al., 2002]. DNA content may be normalized to wet and dry weights.
WW and DW can be used to calculate the water content. GAG content was be assessed
using the 1,9-dimethylmethylene blue (Sigma-Aldrich) dye-binding assay adapted for
microtiter plates with shark chondroitin-6-sulfate (Sigma-Aldrich) standards [Farndale
et al., 1982]. An aliquot of the proteinase K was hydrolized in 12 N HCl at 110 ◦C for 16
h, dried, and then resuspended in assay buffer [Stegemann and Stalder, 1967]. Then,
orthohydroxyproline (OHP) content was measured by a colorimetric assay scaled to
microtiter plates, which involves reactions with chloramine T and dimethylaminoben-
zaldehyde [Stegemann and Stalder, 1967]. Collagen content was determined by assum-
ing a 1:7.64 OHP-to-collagen mass ratio [Hollander et al., 1994]. GAG and collagen
content may be normalized to WW, DW, or DNA content.
These assays were performed to quantify major ECM components and DNA, an
indirect measure of cellularity.
2.1.5.6 Cell Viability and Metabolism
Constructs were halved, stained with a LIVE/DEAD® Assay Kit, and their cross-
section and/or surface was imaged using a confocal microscope (either Olympus Flu-
oview FV1000, Waltham, MA, USA or Leica TCS SP5, Wetzlar, Germany).
In preservation studies (Chapter 6), individual constructs were incubated in 1 mL
of 0.5 mg/mL 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT,
Sigma-Aldrich) in MOPS medium for 3 h to measure metabolism. Then the con-
struct was removed, minced, and placed in dimethyl sulfoxide/isopropanol solution.
Dye absorbance was measured on a microplate reader at 670 nm.
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2.1.5.7 Histological Analysis
Samples (half or whole) were fixed in acid formalin ethanol (5% v/v acetic acid, 3% v/v
formaldehyde, 20.3% v/v water, and 70% v/v ethanol) solution [Lin et al., 1997] for ˜24
h at 4 ◦C, then stored in 70% v/v ethanol at 4 ◦C. Samples were serially dehydrated
in ethanol, cleared with Citrisolv (Thermo Fisher Scientific), and embedded in paraffin
(Thermo Fisher Scientific). Embedded samples were sectioned in 5 or 8 μm slices, and
mounted on slides.
Slides were dewaxed, rehydrated, and stained. GAG distribution was shown via
Alcian Blue (Sigma-Aldrich) or Safranin O staining. Collagen distribution was shown
via Picrosirius Red (Sigma-Aldrich) staining. Stained slides were photographed us-
ing a stereoscope and a Canon Rebel SLR camera (Tokyo, Japan) and merged with
Photoshop (Adobe Systems, San Jose, CA, USA).
These assays were performed to qualify major ECM components.
2.1.6 Statistical Analyses
Unless otherwise noted, statistical significance (p ≤ 0.05) was determined using Statis-
tica (Statsoft, Tulsa, OK, USA) through one- or two-way analysis of variance (ANOVA)
tests, followed by a Tukey honest significant difference (HSD) post-hoc test (α = 0.05).
Results are displayed as mean ± standard deviation.
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Chapter 3




While supply of OC allografts is limited [Paige and Vacanti, 1995, Mow et al., 1991,
Langer and Vacanti, 1993], tissue engineering of OC allografts may provide a cell-based
method for generating additional replacement tissues. Our lab has engineered OC grafts
composed of a viable cell-seeded chondral layer atop a porous bone or bone-like base [Ng
et al., 2010,Lima et al., 2008a,Lima et al., 2004]. Previous research into the bony base
has promoted the use of porous metals, such as tantalum, over devitalized bone [Lima
et al., 2008b] with successful evaluation of the metal in vivo [Ng et al., 2010].
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Recently a selective laser melting technique was reported to fabricate porous tita-
nium structures for orthopaedic applications [Mullen et al., 2009, Mullen et al., 2010,
Stamp et al., 2009]. Titanium is a corrosion resistant, biocompatible material with a
high strength-to-weight ratio [Stamp et al., 2009, Santos et al., 2004]. The SLM tech-
nique offers the valuable ability to select pore size and strut orientation to optimize
bone ingrowth (i.e. 100-700 μm pore size, 60-80% porosity, >50 MPa compression
strength) [Mullen et al., 2009, Kienapfel et al., 1999, Bobyn et al., 1980, Bobyn et al.,
1999a,Nilles et al., 1973,Hulbert et al., 1970,Assad et al., 2003] as well as the potential
for fabricating anatomically contoured shapes to match native geometry [Hung et al.,
2003]. A similar process is currently utilized by Stryker Orthopaedics to manufacture
tibial trays and patellar components for clinical use.
To our knowledge, only one other group has investigated porous titanium as a base
material for engineered bilayered OC grafts [Duan et al., 2013], however their study
utilizes a different titanium fabrication method, cell source, and scaffold. While their
in vivo work shows promise, they only culture constructs for 7 days, and do not report
mechanical or biochemical data.
The main objective of this chapter was to adopt and evaluate porous titanium dow-
els, fabricated through selective laser melting, as a bone-like base for tissue engineered
OC constructs using the agarose-chondrocyte system. Our investigation focused on
characterization of the bases’ structure, their influence on measured construct mechan-
ical properties, and their compatibility for viable OC growth.
Additionally, porous PCL bases are evaluate for compatibility as an alternative OC
graft base material. As metal implants may not be preferred by all surgeons, this
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biocompatible, biodegradable material was evaluated as well. It has been utilized in
other cartilage tissue engineering applications [Lee et al., 2010,Moutos et al., 2010,Lee
et al., 2014,Mrosek et al., 2010].
3.2 Fabrication and Structural Characterization of
Porous Titanium Bases
3.2.1 Methods
Cylindrical titanium disks of 4 and 10 mm diameter and 7 mm height were fabricated
from commercially pure titanium (Sumitomo, Japan) by Stryker Orthopaedics using an
MCP Realizer 2, 250 SLM system (MCP Tooling, Technologies, Staffordshire, UK). The
system uses an ytterbium fiber laser (600 W power CW, λ = 1.06 μm) with an optical
system used to control the movement of the nominal 50 μm diameter focused laser spot
on the build area to a positional accuracy of ±5 μm. The system operates in an over
pressure argon environment with processing chamber oxygen levels below 0.2%. The
atmosphere within the chamber is circulated and filtered to remove process bi-products
(titanium nanopowder formed from condensed titanium vapor) from the recycled gas.
Parts were built in a layer-wise fashion on a substrate plate connected to an elevator
that moves vertically downwards allowing the controlled deposition of powder layers at
50 μm intervals. Upon completion of the build, the substrate plate was removed from
the build chamber and all un-fused powder was recycled. Test pieces were then cut
from the substrate plates. All individual parts were ultrasonically cleaned, dried, and
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heat treated (1400 ◦C for 3 h) prior to testing.
Bases were produced with uniform 600, 900, and 1200 μm unit cell pore size with
regularly oriented cells of struts (0.2 μm thick). Groups are referenced by their unit
cell pore size. Representative scanning electron microscopy (SEM) images have been
published by Mullen et al. [Mullen et al., 2009].
As used to characterize trabecular bone, height, diameter, and weight were measured
for each construct. Bases were placed in distilled deionized water, degassed, and the
submerged weight was measured. From these parameters, the apparent density (ρ) was
calculated from the mass and bounding volume. The true density (ρs, i.e., density of
titanium) was calculated through Archimedes Principle. Metal volume fraction (V F )
was calculated as V F = ρ/ρs. Porosity (P ) was then calculated as P = 1 − V F =
1 − (ρ/ρs).
Bases were photographed from the top and side (Fig. 3.1A) with a stereoscope
(n = 4). The length of the side of the visible pore square (n = 6 pores per base)
and strut size (n = 6 pores per base) were measured from images using ImageJ (NIH,
Bethesda, MD, USA, Fig. 3.1B). The measured side length was squared to estimate
the cross-sectional area of the pore. The images were processed in ImageJ and the
pore area fraction was calculated (Fig. 3.1B). Statistical analyses were performed as
described in 2.1.6.
3.2.2 Results
Apparent density, volume fraction, porosity, pore side length, and pore area fraction
were significantly different (p ≤ 0.001) for 600, 900, and 1200 μm pore unit cell size
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Figure 3.1: (A) Representative stereoscopic images of 10 mm porous titanium disks
with uniform pore distribution; (B) Top: Strut thickness (ˆ) and pore side length (*)
shown on a 1200 μm unit cell pore size base; Bottom: The same base processed for area
fraction measurements. Scale bars in mm.
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groups with minimal variation within groups (Table 3.1, unshaded). For reference, the
measured true density (Table 3.1, unshaded) matched that expected of titanium, 4.5
g/cm3 [Haynes, 2013]. There was no significant difference (p = 0.11 − 0.99) in strut
thickness. Pore area fraction values were similar from top and side views and were
pooled with minimal variation.
Table 3.1:
(Unshaded) Properties of regularly oriented 600, 900, and 1200 μm porous titanium
bases: Apparent density (n = 11 − 12); true density (i.e. density of titanium or
tantalum, n = 11 − 12); metal volume fraction (n = 11 − 12); porosity (n = 11 − 12),
pore side length (n = 6 pores per 4 bases per top and side), strut thickness (n = 6
pores per 4 bases per top and side); and pore area fraction (n = 4−6 per top and side).
(Shaded) Properties of additional bases: randomly oriented 600 μm porous titanium
(n = 11 − 12 for apparent density, true density, metal volume fraction, and porosity;
n = 4 per top and side for pore area fraction) and porous tantalum (n = 6 for apparent
density, true density, metal volume fraction, and porosity; n = 4 per top and side for
pore area fraction). Data are expressed as mean ± standard deviation. Letters indicate
significantly different groups (p ≤ 0.001).
The final column summarizes obtained the linear regression value and R2 obtained from
testing acellular samples on bases or on an impermeable platen (see Fig. 3.3). Slopes
for 600-Random and tantalum groups stem from n = 15 and n = 9 points, respectively.
Each linear regression slope is significant (p < 0.001). Slopes for the 1200 µm and
tantalum groups are each significantly different from all other groups. The slope for the
900 µm group is not significantly different from that of either 600 µm group, however
the 600 regular and random groups have significantly different slopes (p < 0.05).
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3.3 Mechanical Influence of Porous Base
3.3.1 Methods
Acellular agarose disks were cast at 2, 4, and 6% w/v of dimensions 4 mm diameter and
2.3 mm thickness as described in 2.1.1.2. Agarose disks were mechanically as described
in 2.1.5.1 to acquire the EY. Each construct was tested twice, once on an impermeable
surface (chondral) and once centered on top of a 10 mm diameter titanium disk of 600,
900, and 1200 µm pores (fabricated as mentioned in 3.2.1) with time in between testing
procedures for relaxation (osteochondral). The resulting points for each base type were
plotted and fit with a linear regression.
The (on top) testing method was validated by comparing the EY of acellular chon-
dral samples tested on top of regularly oriented 1200 μm porous titanium base and
of osteochondral samples cast into the porous bases (n = 4 − 5) where the gel was
integrated into the pores. No significant differences (p = 0.73) were observed between
the testing configurations, suggesting that the on top test is able to capture the criti-
cal features of the gel-pore interactions that influence chondral (region) properties The
slopes of these regression lines were plotted against their respective unit cell pore size,
and the measured pore side length, pore cross-sectional area, pore area fraction, poros-
ity, and apparent density (mean values) for the regularly oriented titanium bases. The
appropriate intercept was added when applicable (i.e., a non-porous base would have
a porosity of 0). Linear regressions were applied to each plot, and R2 values were
compared. In order to better understand these results in the context of other types
of porous metal bases, this mechanical testing procedure was repeated with randomly
45
oriented 600 µm porous titanium bases [Mullen et al., 2010] and porous tantalum bases
(25 mm diameter disk, courtesy Zimmer Biomet) [Lima et al., 2008a], which also show
randomly oriented pores (Fig. 3.2). The apparent density, true density, metal volume
fraction, porosity, and pore area fraction were measured as described in 3.2.1. The
dimensions of individual pores in these additional bases could not be obtained from
image analysis as the pore sizes vary considerably. Note that despite the same unit cell
pore size, randomly oriented porous titanium bases contain a higher average pore size
than their regular counterparts [Mullen et al., 2010]. When available, the additional
measurements of the randomly oriented bases were pooled with those of the regular
bases, plotted, and then fitted for correlation purposes.
Regression lines and their statistical comparisons were determined through the
method of least squares and regression analysis (p ≤ 0.05 considered significant) using
Microsoft Excel (Redmond, WA, USA). All other statistical analyses were performed
as described in 2.1.6.
3.3.2 Results
By simply mechanically testing acellular constructs atop the porous bases, measurable
drops in mechanical properties were observed, exacerbated with increasing pore size
(Fig. 3.3 and Table 3.2). Linear fits (R2>0.9) indicated that the apparent EY of gel
disks tested on 600 μm pore size disks averaged 87% of the true EY. This attenuation
was 78% for 900 μm and 54% for 1200 μm pore size disks (Fig. 3.3 and Table 3.1, un-
shaded). In order to better understand this effect, these characterization processes were
repeated with randomly oriented 600 μm pore titanium and tantalum bases, yielding
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Figure 3.2: Representative stereoscopic images of 10 mm diameter 600 µm randomly
oriented porous titanium and 4.7 mm diameter porous tantalum. Scale bars in mm.
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attenuation values of 73% and 85% (R2>0.9), respectively (Table 3.1, shaded). Each
regression line slope was significant (p < 0.001). Slopes for the 1200 µm and tantalum
groups are each significantly different from all other groups. The slope for the 900 µm
group is not significantly different from that of either 600 µm group, however the 600
regular and random groups have significantly different slopes (p < 0.05). The slopes
obtained from these mechanical tests were correlated with the measured geometric pa-
rameters, yielding stronger influence of pore size and area parameters (R2≥0.89) than
bulk parameters, such as apparent density and porosity. Adding additional bases to
these plots lowered the R2 values, but maintained the trends (Table 3.2). The disparity
between gel measured mechanical properties on top of porous bases and gel-alone was
caused by the gel bulging/displacing into the base’s pores, as visualized by cutting a 10
mm diameter, 1200 µm pore base in half, then using the microscope-mounted device to
image a 4% w/v agarose disk (cells added for speckle) compressing into the cut base.
By analyzing the area above the struts, it could be seen that there was a decrease in
strain magnitude over the pores relative to strut regions (Fig. 3.4). As this attenuation
was lowest using the 600 μm pore bases, this pore size was utilized for the cellular study.
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Figure 3.3: (A) Schematic: mechanically testing EY of acellular agarose hydrogels on
an impermeable surface (Echondral, left) and atop a porous titanium base (Eosteochondral,
right). Relationship between Echondral and Eosteochondral using (B) 600; (C) 900; (D) and
1200 μm pore bases using 2, 4, 6% w/v agarose. Curve-fit slopes (R2>0.9) are indicated
above graphs. For each scatterplot, n ≥ 14.
Table 3.2: Goodness of fit (R2) for regression lines from plots of the Eostechondral/Echondral
slope values as a function of listed parameters (mean values) including only regularly
oriented 600, 900, and 1200 µm porous titanium bases (left) or including regularly
oriented 600, 900, and 1200 µm porous titanium, randomly oriented 600 µm porous
titanium, and porous tantalum (right). As the unit cell pore size for tantalum was not
known, it was not included in this plot. Pore side length could not be measured for
either randomly oriented structure, so no additional plots could be made for related
parameters (marked “N/A”).
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Figure 3.4: A representative composite of transmitted light and fluorescent light images,
showing 4% agarose gel compressed against a cut 1200 µm pore titanium base (20%
applied strain, cells seeded for speckle) with overlaid compressive strain map (left).
Open pores abutting gel are marked with # and struts abutting gel are marked with
ˆ. Compressive strain across the solid white line plotted (right) indicating increased
compressive strain over struts (ˆ) compared to pores (#).
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3.4 Fabrication, Culture, and Evaluation of Cell-
Seeded OC constructs: Viability
3.4.1 Methods
P2 adult canine chondrocytes were cast on 4 mm diameter, 600 µm pores size titanium
bases with a 2 mm thick chondral region and 4 mm diameter, 2.3 mm thick chondral-
only constructs as described in 2.1.1. Constructs were cultured according to 2.1.2 for
35 days. Chondral constructs were evaluated at days 0, 14 28, and 35. OC constructs
were only evaluated at day 35. Evaluation consisted of spatially-averaged mechanical
properties (2.1.5.1), biochemical analyses (2.1.5.5), histological analyses (Alcian Blue
and Picrosirius Red stains, 2.1.5.7), and viability staining (2.1.5.6). OC constructs were
also evaluated for interface shear strength as described in 2.1.5.2. Statistical analyses
were performed as described in 2.1.6.
3.4.2 Results
OC constructs cast on 600 µm pore bases grew to 334±86 kPa equilibrium Young’s
modulus (Fig. 3.5A), which is in the range of native adult canine tissue (>200 kPa [Ng
et al., 2010]). This was significantly higher than chondral-only controls (p ≤ 0.05).
Dynamic modulus, GAG content, and collagen content were all similar between OC
and control constructs (Fig. 3.5B-D). There were no ostensible differences in construct
opacity (Fig. 3.5E) or cell viability (Fig. 3.6A) between groups.
Histology (Fig. 3.6B-C) corroborated biochemical assay data. Staining patterns
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and intensities were visually similar between control and OC groups for both GAG and
collagen stains at day 35. Note that OC groups had been removed from the base prior
to fixation, so it is understandable that while the control group shows a dark border of
collagen staining around the edges, the OC group shows this pattern around contained
edges but not at the gel-base interface.
Destructive shear testing yielded a peak load of 0.63±0.15 N, stiffness of 1.86±0.54
N/mm, and ETF of 23.55±6.52 J/m2 describing the gel-base integration strength (n =
5).
3.5 Fabrication, Culture, and Evaluation of Cell-
Seeded OC constructs: Depth-Dependent Me-
chanical Properties
3.5.1 Methods
Another batch of OC constructs were cast to the same specifications (as described in
2.1.1) using P2 juvenile bovine chondrocytes on 600 and 1200 µm bases along with
chondral-only controls. On day 35, OC constructs were removed from the bases us-
ing a razor blade. They and chondral-only constructs were halved and stained with a
LIVE/DEAD® Assay Kit for contrast. Depth-dependent properties were evaluated as
described in 2.1.5.3 to acquire local strains. Data were minimally cropped to remove
edge effects, and then binned into 10 equal regions through the thickness of the con-
struct. For each construct, strains were averaged and normalized by the bin with the
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Figure 3.5: (A) Equilibrium Young’s modulus; (B) and dynamic modulus measured
at 0.01 Hz across days 0, 14, 28, and 35 (n = 3 − 4 for days 0, 14, 28; n = 8 for
day 35); (C) GAG/WW; (D) and Collagen/WW at day 35 (n ≥ 7); (E) construct
photos (chondral, top; osteochondral, bottom) at day 35. Data are expressed as mean
± standard deviation. * indicates significantly different groups (p ≤ 0.05).
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Figure 3.6: Day 35 representative cross-sectional images for (A) LIVE/DEAD® (n =
1), (B) Alcian blue (n = 3), and (C) Picrosirius red (n = 3) staining for chondral-only
control (top) and osteochondral (bottom) constructs. OC constructs are positioned with
the gel’s top surface facing right. Scale bar indicates 1 mm.
most compressive strain (εmin) to facilitate presentation of the strain distribution.
3.5.2 Results
The measured depth-dependent strain profiles of OC and chondral constructs are pre-
sented in Fig. 3.7. The maximum compressive strain in chondral constructs was located
in the construct’s cross-sectional center, yielding a “U-shape” profile with the central
bin significantly more compliant (p ≤ 0.05) from the distant edge (Fig. 3.7D-E). Fig.
3.7F-H visualizes these strain profiles on the constructs.
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Figure 3.7: (A) Schematic of microscope-mounted depth-dependent testing setup,
adapted from [Wang et al., 2003a]. (B) Representative strain map of control construct
showing “U-shape” profile with bins demarcated. Average strain profiles normalized
by peak compressive strain for (C) chondral-only controls; and for osteochondral con-
structs grown on (D) 600; and (E) 1200 μm pore bases. * indicates significantly different
groups (p ≤ 0.05). For each group, n = 3 − 4. (F-G) Respective average strain profiles
contextualized on schematics of chondral-only and osteochondral constructs. Data are
expressed as mean ± standard deviation.
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3.6 Evaluation of PCL as a Porous OC base
3.6.1 Methods
PCL (Sigma-Aldrich) was obtained, heated to ˜85
◦C, extruded in a raster fashion to
fabricate 20 mm diameter, 4 mm thick disks with ˜500 µm spacing between filaments,
and then subpunched to 6 mm diameter. P1 canine chondrocytes were cast atop these
bases (PCL group) or cast as a slab and punched at 6 mm diameter (chondral control
group) as described in 2.1.1. Gel thickness was ˜1.7 mm for both groups. Constructs
were cultured for 28 days according to 2.1.2, and then evaluated for mechanical (2.1.5.1),
biochemical (2.1.5.5), histological (Alcian Blue and Picrosirius Red stains, 2.1.5.7), and
viability properties (2.1.5.6) on Day 28.
3.6.2 Results
PCL OCs grew to a similar EY as controls with similar GAG/WW; however colla-
gen/WW content was significantly lower (Fig. 3.8A-C). Gross morphology (Fig. 3.8D)
and LIVE/DEAD® staining (Fig. 3.8F) did not show any ostensible differences in
opacity or viability between chondral and OC constructs grown on PCL bases.
3.7 Discussion
The main goal of the work described in this chapter was to explore porous titanium as
a bone-like base for tissue engineered osteochondral constructs. Here, we displayed the
ability to culture titanium-based OC constructs to achieve native levels of the equilib-
56
Figure 3.8: Day 28 (A) Equilibrium Modulus (Chondral-only: n = 7;PCL: n = 6); (B)
Dynamic Modulus (Chondral-only: n = 7;PCL: n = 6); (C) GAG/WW (Chondral-
only: n = 22;PCL: n = 13); (D) collagen/WW (Chondral-only: n = 20;PCL: n = 12);
(E) Gross image of PCL (left) and Chondral (right) constructs; (F) LIVE/DEAD®
images of PCL (top, n = 2) and Chondral (bottom, n = 1) constructs. * indicates
statistically significantly difference from control (p < 0.001). Scale bar: 1 mm.
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rium Young’s modulus (Fig. 3.5A) using a clinically relevant adult cell source as previ-
ously done with tantalum-based OC constructs [Lima et al., 2008a,Ng et al., 2010]. This
EY and the corresponding biochemical content was similar or higher than that of the
chondral-only controls, indicating that, while the titanium struts may block some nutri-
ent transport to the cartilage layer, the inherent beneficial elevation of the cell-seeded
hydrogel off the culture dish surface may overcome this effect [Bian et al., 2009a,Cigan
et al., 2014]. Additional measurements not reported here confirm repeated ability to
grow cartilage tissue on titanium without detriment to cell viability. The incorpora-
tion of the base did not ostensibly alter internal tissue growth patterns. Chondral-only
constructs have been shown to grow with a “U-shaped” strain profile across its depth
(Fig. 3.7B-C, F) [Kelly et al., 2006], meaning that the center, where nutrient transport
is most limited, is relatively softer than the periphery. Here, OC constructs appeared
to have this pattern shifted toward the gel-titanium interface (Fig. 3.7D-E), implying
that the “U-shape” may continue into the overlap region (Fig. 3.7G-H). The location
of the softest tissue region above the interface could decrease integration between the
cartilage and the underlying cartilage. Previously our group had reported integration
strength for agarose-tantalum OC constructs grown with juvenile bovine chondrocytes
which were comparable with other engineered OCs [Allan et al., 2007], yet below the
native range [Lima et al., 2008a]. The values reported here for titanium-based OC con-
structs grown with adult canine chondrocytes were slightly lower than those reported
for juvenile bovine chondrocytes and tantalum, which is consistent with canine native
and engineered tissues being less stiff than corresponding bovine tissues. Still, the pres-
ence of the porous base decreased the cartilage layer’s ability to sustain interstitial fluid
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pressurization [Lima et al., 2004], allowing for fluid to exude through the construct’s
bottom, where there is generally an impermeable surface during mechanical testing.
This is exemplified by the OC constructs’ dynamic modulus (Fig 3.5B), which, unlike
the Young’s modulus, is not higher than that of the control. Gel penetration into the
pores of the underlying substrate (with applied loading) resulted in a lower effective
modulus than gels tested on impermeable surfaces (Table 3.1, Fig. 3.3). Correlation
analysis indicates that this mechanical effect is a greater function of the size of the pores
than of the porosity or density (Table 3.2). However, as noted from the decrease in cor-
relation due to randomization of the pore structure, it may be difficult to define a single
parameter of the porous substrate that is responsible for the attenuated properties of
the overlying gel, particularly since many of these descriptive parameters are inherently
interrelated. Moreover, parameters such as pore shape, strut geometry, and pore-pore
interconnectivity that can be modified in fabrication may also influence the apparent
mechanical properties of the composite graft. Nevertheless, this study offers new in-
sights to the complexity of the gel-pore interactions, which may dramatically influence
the effective mechanical properties of osteochondral grafts and should be considered in
the design of porous bases for this purpose. We anticipate that with the precise fabrica-
tion control offered by the additive manufacturing technique, these negative effects may
be minimized with proper structural alterations to the base. As indicated by the small
scatter in the measured properties of porous titanium bases (Table 3.1), the manufac-
turing technique allows for precise control of different pore sizes (Table 3.1), each in the
optimal range of porosity reported for bone ingrowth [Mullen et al., 2009]], with a tita-
nium volume fraction similar to that of trabecular bone (23.2±5.7% in the femoral neck
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and 10.7±4.0% in the proximal tibia [Liu et al., 2008]). Such precision and control over
the material fabrication is ideal for fine-tuning of the structure, to optimize both bone
integration and engineered cartilage growth in a reproducible manner. In principle, this
additive manufacturing technique could be used to incorporate an impermeable layer
separating the gel-metal overlap region from the rest of the base (Fig. 3.9). This is
expected to prevent bulging and increase interstitial pressurization by blocking fluid
exudation from the bottom face, thus mimicking the mineralized subchondral plate in
the native joint [Hwang et al., 2008]. Such a feature will be especially critical when
engineering larger anatomic articular layers, which may not have surrounding tissue to
buttress loading of the engineered tissue. Additionally, bases could be fabricated with
different pore sizes and orientations above and below the impermeable layer, to inde-
pendently optimize for osteointegration of the engineered OC graft on the bony side,
and cell-seeded gel integration and nutrient transport on the chondral side. Future
studies will aim to fabricate, characterize, evaluate in vitro and in vivo, and optimize
titanium-based osteochondral constructs to best mimic native allografts.
Despite success engineering robust cartilage atop metal implants [Lima et al., 2008a,
Nover et al., 2015c] and success in in vivo applications [de Wild et al., 2013,Ng et al.,
2010,Bobyn et al., 1999a,Bobyn et al., 1999b], many are looking for alternative materials
for implants. Metals may cause interference with imaging modalities [Levi et al., 1998]
and may be difficult to remove in the case of revision [Mrosek et al., 2010]. PCL may
provide such alternative as it is a bioresorbable, biocompatible polymer, which can
be fabricated to different pore sizes/geometries [Zein et al., 2002, Lee et al., 2010, Lee
et al., 2014] and has shown to integrate with cancellous bone [Feczkó et al., 2003].
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Figure 3.9: Schematic (left) and gross photo (right) of an OC construct with a mul-
tilayered bases consisting of a cell-seeded chondral region (a), a gel-integrating region
(b), an impermeable interface (c), and a bone-integrating region (d).
Here, we show ability to use PCL as a bone-like base for engineered OC constructs.
PCL OC constructs grew to similar EY and GAG/WW as chondral control constructs.
Elaborated tissue properties were lower than native, which is expected as these larger
(˜6 mm diameter) constructs have greater diffusional limitations [Bian et al., 2009a].
Similar to the titanium OC constructs, G* was lower for the OC group compared to
the control. There was significantly less collagen in PCL constructs than in controls,
which may be an artefact of removing the chondral region from the base, since collagen
is often distributed along the periphery of the construct, a portion of which lies in the
interface region. This will require further investigation.
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Focused Ultrasound Approach for
Local Tissue Property Modulation
4.1 Introduction
Native tissue contains a mineralized subchondral plate, which anchors mature cartilage,
separating it from the underlying vascularized bone, providing a virtually imperme-
able interface (Fig. 1.6). This subchondral interface promotes the elevated interstitial
fluid pressurization needed for load-bearing and lubrication mechanisms in articular
cartilage [Hwang et al., 2008, Soltz and Ateshian, 1998, Park et al., 2003, Pan et al.,
2009, Krishnan et al., 2004]. However, engineered osteochondral tissues, consisting of
a chondrocyte-seeded hydrogel atop a nonliving porous, bone-like substrate, lack any
sort of subchondral plate a priori. Incorporation of such an impermeable layer from
the start, such as via a denser porosity region in the bony substrate localized to the gel-
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substrate overlap region [Sherwood et al., 2002], would block nutrient transport across
the layer during tissue culture. Since nutrient transport is critical for the development
of engineered tissue [Bian et al., 2009a, Leddy et al., 2004], a technology is required
that can stiffen or seal the bone-cartilage interface at an optimal time during in vitro
growth.
HIFU may offer such an ability. Like other forms of ultrasound, HIFU is a min-
imally or non-invasive, non-contact, non-radiation, low-cost technology. It is under
investigation for its use in soft-tissue cancer therapy [Fischer et al., 2010] and is cur-
rently FDA approved for uterine fibroid [Hesley et al., 2008, Stewart et al., 2003] and
prostate tissue [Mearini et al., 2014, Dickinson et al., 2013] ablation. HIFU can pen-
etrate depths of at least 10 cm and reach temperatures of at least 80 ◦C [Hill and
Ter Haar, 1995,Kennedy, 2005]. Studies have shown that HIFU’s thermal and mechan-
ical effects can lead to a loss of in vitro viability [ter Haar et al., 1980], yet the thermal
effects of HIFU remain the primary mechanism of damage [Hill and Ter Haar, 1995]
and repair tissues enter the periphery of the treated region after two weeks [Kennedy,
2005].
In conjunction with heat, an additional substance may be necessary for inducing
a change in tissue properties. Heat-induced protein denaturation has been demon-
strated in a number of tissues and protein-incorporated gel phantoms, often leading to
color change, coagulation, and, after certain temperatures, irreversible stiffening [Shah-
mirzadi et al., 2014, Nandlall et al., 2010, Lafon et al., 2005, Wu et al., 2001, Chen
et al., 2007,Divkovic et al., 2007, Iizuka et al., 1999,Takegami et al., 2004,Maleke and
Konofagou, 2008]. Albumin is commonly used in gel phantoms for tissue ablation stud-
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ies via thermal treatment modalities, such as HIFU [Chen et al., 2007,Divkovic et al.,
2007, Iizuka et al., 1999, Takegami et al., 2004, Hynynen, 1990]. Albumin, BSA or egg
white, a more economical option, coagulates at 67±1 ◦C via intermolecular β-sheet for-
mation, changing from a clear color to an opaque white, providing easy visualization
of the heated region [Divkovic et al., 2007,Nandlall et al., 2010]. Outside of phantoms,
albumin has been utilized as a biological solder [Noguera et al., 2007]. With respect
to articular cartilage, albumin is relevant; it is the chief protein component of synovial
fluid [Hui et al., 2012]. For these reasons, the addition of albumin may aid the alter-
ation of internal properties of tissue engineered constructs, especially prior to cellular
protein elaboration.
While most research utilizing HIFU technology aims to induce pressures and/or
thermal elevation over large (cm scale) areas of dense tissue in vivo, such as in full
tumor ablation, here HIFU is investigated as a potential tool for precisely modulating
the spatial properties of small (mm scale) tissue engineered constructs during in vitro
growth, which increase in density during culture (agarose gel scaffold is 98% w/v water
on initial seeding day). Here, the aim of this study is to test the feasibility of HIFU as a
method of altering local tissue properties as a tool for tissue engineering, namely forming
a biomimetic subchondral plate in engineered osteochondral constructs by thermally
affecting the interface region.
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4.2 Spatiotemporal Control of HIFU/Power Opti-
mization
4.2.1 Methods
HIFU setup is described in 2.1.3 and depicted in Fig. 2.1 and shown again in 4.1A.
An example of irreversible, heat-induced protein denaturation and stiffening in a
gel phantom is displayed and described in Fig. 4.1B-C.
Controlled patterning of thermally affected regions were induced in acellular, albumin-
containing agarose (Type VII) phantoms by moving a therapeutic transducer in a 2D
raster-scan fashion.
Thermally affected regions were produced at various powers and durations on acellu-
lar, albumin-containing osteochondral constructs (agarose Type VII) cast atop 10 mm
diameter titanium disks. The lowest combination inducing consistent albumin color
change was selected for subsequent osteochondral interface heating studies.
4.2.2 Results
HIFU treatment could be induced at variable depths below the gel surface (Fig. 4.1D),
and formed into patterns based on the movement of the transducer and the duration
of the treatment. On porous titanium bases, 20 s of treatment at 11.6 W total acoustic
power was found to reliably produce a visible thermally affected region (Fig. 4.1E).
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Figure 4.1: (A) Schematic of HIFU treatment of osteochondral construct. The two-
transducer system is attached to a computer-controlled positioner. (B-C) Circular
thermally affected region induced in an egg white gel by HIFU with a 25 s duration
in the center and 10 s duration in the surrounding ring (˜6 MPa peak in situ posi-
tive pressure), which was then mapped using HMI using a rastered step size of 1 mm
across a 15 x 15 mm2 region (peak-positive pressure of 1.98 MPa, 500 ms/point dura-
tion). The circular egg-white pattern indicated that the thermally affected region was
three times stiffer than the surrounding gel. (B) Gross Image and (C) HMI map of
HIFU-induced thermally affected region. Color bar shows oscillatory displacement in
µm (lower displacements correspond to stiffer regions). (D) Thermally affected region
patterns beneath the surface of agarose-egg white gel (Top and Side views). (E) Osteo-
chondral constructs (Top and Side views) displaying thermally affected regions created
at different powers. Arrows indicate 11.6 W total acoustic power for 20 s. Scale bars
indicate millimeters.
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4.3 Albumin Incorporation in Engineered Constructs
4.3.1 Methods
P2 juvenile bovine chondrocyte-seeded constructs were cast using Type IX-A agarose
(see: 2.1.1) creating the following groups: control samples (without albumin); egg
white-containing constructs; and 5% w/v BSA (cast by mixing equal volumes of 120×106
cells/mL suspension and 20% w/v BSA in PBS, then mixing equal volumes of this so-
lution with 4% w/v agarose). For the duration of a 28-day period, constructs were
mechanically tested (2.1.5.1) for G* at 0.5 Hz and biochemically assayed for GAG
content (2.1.5.5).
Statistical analyses were performed using one-way ANOVA tests according to 2.1.6.
Here, Microsoft Excel was utilized to calculate the 95% confidence interval (CI) of group
means and differences between means. Data is displayed as mean ± 95% CI.
4.3.2 Results
Albumin-containing constructs grew to a similar extent as the controls (Fig. 4.2).
Compared to the control’s G*, the mean difference was 0.24±0.34 MPa for egg white-
containing constructs and 0.31±0.29 MPa for BSA-containing constructs. Compared
to the control’s GAG content per dry weight (g/g), the mean difference was 0.04±0.03
for egg white-containing constructs and 0.02±0.03 for BSA-containing constructs.
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Figure 4.2: Unimpeded growth in constructs with incorporated albumin. (A) G* at 0.5
Hz (n = 6 per group) and (B) GAG content per dry weight (n = 4 − 6 per group) of
chondrocyte-seeded agarose constructs: control, and egg white or BSA supplemented
on day 28. Error bars show 95% CI. The dashed line represents the mean of day 0
values across groups (n = 3 − 4 per group).
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4.4 Post-HIFU Effects on Solute Transport
4.4.1 Methods
An acellular albumin-containing gel (agarose Type VII) slab of 2.3 mm thickness was
cast (2.1.1.2), pinned across rubber stoppers, and placed in a degassed PBS/ 1%
antibiotic-antimycotic solution. HIFU was applied using 11.6 W total acoustic power
in a raster pattern to induce thermally affected focal regions across a 14×14 mm square
plane of the gel (15×15 points, 10 s/point). Cylinders (3 mm diameter) were punched
from affected gel region. Disks were washed twice with PBS/10% antibiotic-antimycotic
solution, then soaked in a saturated 0.5 mg/mL 70 kDa fluorescein-conjugated dextran
(Invitrogen) solution, and then imaged using a confocal microscope (Olympus Fluoview
FV1000).
4.4.2 Results
Fluorescence images of the constructs soaked in fluorescein-labeled dextran showed
uniform distribution of live cells except for regions of rasterized thermally affected
regions that appeared dark where dextran was excluded (Fig. 4.3A). These dark regions
corresponded to those visualized by albumin color-change in transmitted light images.
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Figure 4.3: (A) Setup showing HIFU-induced array of thermally affected regions (left,
inset shows array magnified). Fluorescein-dextran soaked construct viewed under trans-
mitted light to visualize thermally affected sites (top-right) and fluorescence (bottom-
right) showing dextran exclusion from those same sites. (B) Top: Sterile ultrasound
chamber; Bottom: Osteochondral constructs showing HIFU-induced egg white lesion
(left) and no treatment (right). Scale bar: 1 mm.
4.5 Temperature Measurement During HIFU Ap-
plication
4.5.1 Methods
To gain an appreciation for the local heating temperatures associated with HIFU appli-
cation, thermocouple studies were performed on acellular egg white-containing agarose
(Type VII) gels cast on 10 mm diameter titanium bases (gel-bony substrate) or as two
layered slabs (gel-gel). A 40-gauge T-type bare wire thermocouple (Philips Research
North America, Briarcliff Manor, NY, USA) was placed into gel towards the osteo-
chondral interface or between two layered slabs [Wang et al., 2012]. The thermocouple
was targeted by inducing low power heating for 2 s per point in a raster fashion, then
moving toward the point of highest temperature rise (performed in the x-, y-, and z-
directions). Temperature data was recorded for 60 s including a 20 s application of
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0.56 W or 11.6 W total acoustic power on three osteochondral constructs and in three
different locations between the layered slabs (n = 3).
4.5.2 Results
With the application of 0.56 W total acoustic power, temperatures recorded at the gel-
metal interface were in the 26-40 ◦C range while those between the stacked gel layers
were between 23-25 ◦C (data not shown). With 11.6 W total acoustic power, the gel-
metal temperatures were 80-100 ◦C, while the layered gel temperatures were 30-45 ◦C
(Fig. 4).
Figure 4.4: Enhanced temperature elevations with incorporated base. Left : Gross image
of osteochondral construct with HIFU-induced denaturation region with thermocouple
inserted (Arrow). Scale bar indicates millimeters. Temperature readings across 60 s
containing 20 s of 11.6 W total acoustic power excitation at the gel-metal interface
(Top-right) and between layered gels (Bottom-right).
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4.6 Viability & Culture of Cell-Seeded Gel Con-
structs After HIFU Treatment
4.6.1 Methods
To assess cell viability effects, an albumin-containing cellular agarose (Type VII) slab
of 2.3 mm thickness was placed on a silicon rubber/absorber over polyurethane foam
within a 100 mm culture dish and immersed in phosphate buffered saline. A 4.5 MHz
HIFU transducer was used at ˜5.9 W total acoustic power (excitation time: 3 s/point)
to raster thermally affected regions into the slab. The transducer’s focus was aimed to-
wards the bottom of the slab. The slab was punched in thermally treated and untreated
(control) areas using a 4 mm biopsy punch; thermally affected regions were kept within
each disk. For 6 weeks, constructs were maintained with CM, changed every 2-3 days.
Parallel samples from each group were halved, stained for viability, and imaged using
a confocal microscope (Leica TCS SP5) with n = 1 sample per n = 4 time points.
As a more robust follow-up, Passage 4 juvenile bovine chondrocytes were cast in
agarose (Type VII) with albumin on porous titanium bases of 4 and 10 mm diameter,
with a gel thickness of ˜2 mm. To maintain sterility, constructs were sterilely placed
in a custom apparatus with degassed CM, and half were subjected to HIFU treatment.
The custom apparatus uses an acoustically transparent polydimethylsiloxane (PDMS)
membrane to separate constructs in sterile, degassed CM, from a reservoir of non-
sterile degassed, distilled water to which the HIFU system is acoustically coupled. The
10 mm osteochondral constructs were thermally affected in a 3×3 pattern and 4 mm
osteochondral constructs were thermally affected at a single point using a power of
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11.6 W total acoustic power for a 20 s duration. Following treatment, constructs were
removed from the device in a sterile hood, transferred to culture dishes, and cultured
for 28 days in CM with 14 days of 10 ng/mL TGF-β3 supplementation (2.1.2). On days
0 and 28, constructs were evaluated for GAG content. Cell viability was assessed with
a LIVE/DEAD® stain imaged on a confocal microscope (Olympus Fluoview FV1000).
Statistical analyses were performed using one-way ANOVA tests according to 2.1.6.
Here, Microsoft Excel was utilized to calculate the 95% CI of group means and differ-
ences between means. Data is displayed as mean ± 95% CI.
4.6.2 Results
Immediately after the ultrasonic treatment, the thermally affected constructs contained
a region of cell death (ethidium homodimer-1 staining, red; Fig. 4.5A), which corre-
sponded with the white regions of heated albumin. The surrounding regions remained
viable (calcein-AM staining, green). Control constructs remained viable throughout.
Over the six week period, the cell death region remained localized, with some spots of
viability appearing in the dead zone.
In the follow-up study, osteochondral constructs remained sterile following HIFU
treatment. Fig. 4.3B shows the sterile chamber and the egg white lesion induced
in osteochondral constructs. Treatment was verified with the LIVE/DEAD® stain,
showing dead regions which remained localized for 28 days in culture (Fig. 4.5B)
confirming previous results. On day 0, GAG/DW (g/g) was 0.07±0.019 (n = 6) and
0.06±0.003 (n = 3) for 4 mm and 10 mm diameter constructs respectively. On day 28,
this value increased to 0.23±0.045 (n = 7) and 0.24±0.049 (n = 4) for 4 mm and 10
74
Figure 4.5: Cell viability effects remain localized over time. (A) Representative
LIVE/DEAD® staining of the axial cross-section immediately after HIFU (Day 0,
left), and an upper and lower (HIFU treated) transverse plane 14 days post-HIFU
(Day 14, right). Both images show localized cell death due to ultrasound treatment.
Asterisks indicate HIFU treated zone. Arrow indicates area of possible cell recovery.
(B) LIVE/DEAD® images of removed gel regions of 4 mm diameter osteochondral
constructs: control (left) and HIFU-treated (right) 28 days after treatment date.
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mm diameter untreated constructs respectively. HIFU constructs showed similar GAG
levels (4 mm: n = 7; 10 mm: n = 4); the differences in means between HIFU-treated
constructs and untreated controls were 0.02±0.07 and 0.04±0.08 for 4 mm and 10 mm
diameter constructs respectively. These studies repeat the incorporation of albumin
without negative biocompatibility effects.
4.7 Discussion
HIFU is a unique method for applying thermal heating to local tissue regions and at
various depths. Here we show that this technology can be applied to hydrogels used in
tissue engineering. Incorporation of albumin can easily be incorporated upon initial gel
fabrication, allowing for on-demand heat-induced denaturation without affecting tissue
growth. Here we also show that this denaturation can block transport.
This internal reorganization of the egg white-gel scaffold can be utilized in tissue
engineering, such as in the example of replicating a subchondral plate, a stiff, imper-
meable surface between cartilage and bone. This effect may also be delivered by other
incorporable proteins. While this limited transport and increased stiffness may be de-
sirable in a final tissue engineered product, these conditions would impede the in vitro
development of the tissue by limiting nutrient transport to cells elaborating extracel-
lular matrix. The depth penetrating aspects of ultrasound overcome this challenge by
allowing for sterile on-demand treatment during in vitro tissue growth, ideally after a
user predetermined amount of tissue development.
Treating tissues with heat is not unprecedented. In orthopaedics, radiofrequency
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probes and lasers have been utilized in the clinic, however both techniques are associated
with cell death [Good et al., 2009, Protsenko et al., 2008, Shellock and Shields, 2000,
Yasura et al., 2006,Karam et al., 2006]. Here we show that the concomitant cell death
of HIFU treatment remains localized over time with potential areas of recovery, which is
reminiscent of the ability of engineered cartilage to recover after mechanical injury [Tan
et al., 2010]. However, if recovery is poor, further extracellular matrix elaboration in
the HIFU-treated area may be hindered. This suggests that this undesired effect could
potentially be balanced against the intended changes in tissue properties.
From a therapeutic ultrasound perspective, one of the fascinating aspects of these
studies is that these temperature elevations are induced in small, thin, non-dense mate-
rials. As ultrasound energy is deposited where mismatches in impedance occur, abutting
materials can be used to assist the heating. Temperature measurements demonstrate
this effect, showing that at the same powers, temperatures induced at a gel-metal inter-
face is much greater than those at a gel-gel interface. In the case of introducing changes
at an interface, this is quite beneficial.
To aid benchtop HIFU application, a custom chamber was fabricated to hold con-
structs (Fig. 4.3B, top). It can be sterilized and filled with media, degassed for ul-
trasound purposes. A thin membrane, which separates the sterile and non-sterile envi-
ronments, remains invisible to ultrasound, allowing for the beam to travel through it.
When tested, this concept allowed for ultrasonic treatment, maintenance of viable cells
as confirmed by LIVE/DEAD® staining and subsequent in vitro growth.
HIFU treatment will require further optimization in order to realize its full potential
for tissue engineering applications. The appropriate power level related to temperature
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elevation and duration as well as the timing of the treatment will vary for different
tissues and applications. The effects of heating on cell matrix elaborated products may
provide different effects in conjunction with those due to heating the gel scaffold and
egg white. Also, additional research is required to determine how HIFU treatment
modulates interface strength. On balance with the encouraging data that has been
presented herein, HIFU appears to be a feasible tool for invoking changes in internal
tissue properties on a concentrated, localized scale. As HIFU is already used clinically,
it is conceivable that HIFU can also serve as a tool for additional regenerative medicine
strategies in situ. We anticipate that HIFU will become a useful instrument in the field
of tissue engineering research.
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Chapter 5
Strategies for Scaling Up
5.1 Introduction
Our lab has a demonstrated ability to utilize juvenile [Mauck et al., 2000] or adult
chondrocytes [Martin et al., 2000,Bian et al., 2009a,Kelly et al., 2013,Ng et al., 2010]
in an agarose hydrogel scaffold system to engineer articular cartilage grafts, both chon-
dral and osteochondral [Lima et al., 2008a], with native or near-native mechanical and
biochemical properties. Still, in these cases, the engineered grafts were relatively small
in size (diameter: ˜4 mm).
In order to increase the clinical relevance of engineered grafts, it is critical to scale
up their size [Hung et al., 2003]. With larger grafts, the loads affecting the graft may
not be shouldered by surrounding tissue as they are with smaller grafts. This makes
the strength of the graft even more critical.
A challenge for successful scale up is the inherent diffusion of nutrients and other
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chemical factors required to support tissue growth. According to Fick’s law, diffu-
sion time is proportional to the square of the distance [Atkins, 1994]. This transport
limitation may be exacerbated by nutrient consumption [Buckley et al., 2009a] and in-
creased transport resistance arising from dense elaborated tissue within the engineered
construct [Leddy et al., 2004]. Areas of decreased tissue growth in engineered con-
structs have been attributed to gradients in various internal nutrient levels including
glucose and oxygen [Nims et al., 2015, Obradovic et al., 1999, Cigan et al., 2013, Hey-
wood et al., 2006, Sengers et al., 2005, Zhou et al., 2008]. Even in small constructs,
this effect has resulted in preferential matrix deposition in the peripheral rather than
central regions [Kelly et al., 2006,Kelly et al., 2009].
Various methods have been investigated for overcoming this diffusion limitation,
such as dynamic loading [Albro et al., 2008,Albro et al., 2010,Bian et al., 2010a,Hung
et al., 2004,Lima et al., 2007,Mauck et al., 2000,Mauck et al., 2003b], perfusion [Davis-
son et al., 2002], dynamic laminar flow [Vunjak-Novakovic et al., 1999], and orbital
motion [Cigan et al., 2014] utilized to increase convection; microbubbles used to create
internal reservoirs [Lima et al., 2012]; microspheres used to internally release dexam-
ethasone [Roach et al., 2013]; and channels introduced within the tissue to increase
surface area and decrease the nutrient path length [Bian et al., 2009a, Buckley et al.,
2009a,Cigan et al., 2014,Nims et al., 2015].
In the current study, we take a unique approach to this problem by investigating
a strategy in which small, interlocking tissue engineered constructs are individually
cultured to achieve robust tissue properties, and then assembled to provide a graft
capable of covering large defects of variable size and shape in a modular fashion. Proof-
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of-principle studies are presented that explore a single puzzle piece shape (Fig. 5.1)
with preliminary studies exploring a concentric circle strategy. Puzzle assemblies and
concentric circle assemblies are compared to equivalently sized large constructs cultured
under the same conditions.
Figure 5.1: Schematic of puzzle piece strategy. Cell-seeded agarose stained with calcein
for cell visualization. Scale bar: 1 mm.
5.2 A Concentric Circle Approach
As a preliminary study, a concentric circle approach was taken to fabricate large tissues
from smaller individually cultured subunits.
5.2.1 Methods
A concentric triple punch was fabricated via 3D printing to hold three concentric biopsy
punch blades of 4, 6, and 8 mm diameters. P2 juvenile bovine knee chondrocytes were
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cast into 2.3 mm thick slabs as described in 2.1.1, which was then punched with either
an 8 mm diameter conventional biopsy punch (control group) or the concentric punch
(concentric circle, CC group). Each control or CC construct was cultured in individual
plate wells containing 4 mL of CM according to 2.1.2. At day 14, following bulk testing,
controls were concentrically subpunched for radially dependent biochemical analysis
(2.1.5.5, Fig. 5.2A-B, top).
Figure 5.2: Experimental Schematic: (A) Control and separated CC constructs cultured
for 14 days; (B) Controls subpunched for biochemical evaluation (top); CC constructs
reassembled for further culture (bottom); (C) Controls and reassembled CC constructs
cultured from day 14-42.
On day 14, CC constructs were reassembled and cultured for an additional 4 weeks
(Fig. 5.2B, bottom). Mechanical properties of controls were measured. Constructs
were analyzed biochemically (2.1.5.5). Histological assessment was conducted on day
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0, 14, and 42 samples (Alcian Blue and Picrosirius Red, 2.1.5.7). On day 42, viability
staining was conducted (2.1.5.6) as well as a punch-out test, using a 4 mm then a 6
mm diameter platen at 5 μm/s to measure integration of the inner and middle zones of
reassembled CC constructs as compared to freshly subpunched and then reassembled
control constructs.
Student’s t-tests were used to measure statistical significance (p ≤ 0.05).
5.2.2 Results
Controls grew to ˜100 kPa by day 14 (Fig. 5.3A). Because many CC constructs did
not remain flat (Fig. 5.4B), mechanical testing could not be performed. Controls
swelled to a significantly greater diameter (˜8.6 mm) than the CC constructs (˜8.1
mm). Comparing biochemistry by radial section at day 14, the central core of the CC
constructs showed significantly higher GAG and collagen per wet weight than that of
the control. Middle rings also displayed this trend (Fig. 5.3B).
At day 28, assembled CC constructs had significantly higher bulk construct collagen
per wet weight (Fig. 5.3C). Viability staining showed similar viability across both
groups with no cells between segments of the CC constructs (Fig. 5.3D). Compared to
freshly punched and reassembled control constructs, CC constructs showed significantly
stronger integration via push out tests (data not shown) of both the 4 mm diameter disk
and 6 mm diameter ring. CC construct sections could not be fully punched out, since
the load would exceed the load cell limits; instead, stiffness (slope of the linear portion
of the load-displacement curve, n = 3 − 4) was calculated, showing the integration of
the center disk to be ˜40X stiffer in CC constructs.
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Day 14 histology (Fig. 5.4A) showed a more homogeneous distribution of GAG
and collagen in CC constructs with collagen distribution along the peripheries of the
segments. Day 42 staining showed more intense, more homogeneous GAG and collagen
staining in the outer ring areas of the CC constructs. Likewise, gross morphological
images (Fig. 5.4B) showed greater opacity throughout the CC constructs.
5.3 Engineering of Puzzle-shaped Grafts
5.3.1 Methods
Custom punches were designed using Illustrator (Adobe, Mountain View, CA, USA)
and SolidWorks (Dassault Systmes, Vlizy, France), and then 3D printed (Objet24,
Stratasys, Eden Prairie, MN, USA). An interlocking puzzle-shaped punch was designed
to produce a construct with volume similar to that of a 6 mm diameter disk, but
with greater surface area. A square shape punch was designed to produce single large
constructs with equivalent size to an assembly of nine (3×3) puzzle pieces so to serve
as a control.
P2 juvenile bovine knee chondrocytes were cast and as a 2.3 mm thick slab (2.1.1)
and then constructs were excised from the slabs using the custom 3D printed punches
(Groups: “Puzzle” and “Square”). Constructs were cultured for 28 days in volume-
scaled CM (2.1.2). Evaluation was conducted on day 0 (baseline) and day 28.
Local equilibrium Young’s modulus was obtained at a central location by curve-
fitting the load response of a spherical tip indentation stress-relaxation test (10% strain
at 0.5 μm/s, 2.31 mm diameter indenter) using the open-source finite element code
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Figure 5.3: (A) Equilibrium Modulus of control constructs; (B) Radial GAG (top) and
collagen (bottom) per wet weight at day 14; (C) Collagen normalized by wet weight
at day 28; (D) LIVE/DEAD® Stain at day 42: control (top), concentric (bottom). *
indicates statistically significant different groups (p ≤ 0.05).
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Figure 5.4: (A) Alcian Blue (top) and Picrosirius Red (bottom) staining. Day 0, Day
14, Day 42 with controls on top, concentric constructs below. (B) Gross morphological
images. Scale Bars: 1 mm.
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FEBio (www.febio.org, Salt Lake City, UT, USA) [Maas et al., 2012]. Constructs
were modeled as a biphasic material [Mow et al., 1980] with a solid matrix consisting of
a mixture of a neo-Hookean elastic solid (EY, and Poisson’s ratio, ν), representing the
proteoglycan content and a continuous spherical (isotropic) distribution of fibers (fiber
modulus ξ and power law exponent β), representing the collagen content. For reference,
spatially-averaged mechanical properties of whole Puzzle constructs were obtained in
unconfined compression (2.1.5.1). Note that square constructs were not evaluated in
this manner due to their large size. In all cases, construct surface area was measured
from images using ImageJ.
Additionally, halved constructs were evaluated for viability (2.1.5.6), biochemical
(2.1.5.5) and histological (Fast Green/Safranin O and Picrosirius Red with 0.5 mg/mL
testicular hyaluronidase, Sigma-Aldrich, treatment 2.1.5.7) properties.
Statistical analyses were performed as described in 2.1.6.
5.3.2 Results
Two independent studies were conducted, repeating experimental conditions. In the
first study (Study 1), at day 28, Puzzle constructs were opaque across their entire area,
while Square constructs showed opacity only at their periphery (Fig. 5.6A). At the
center, Puzzle constructs displayed a 4.2 fold increase in EY over the square group
(p < 0.05, Fig. 5.6B), based on the FEBio curve fits of spherical indentation responses
(R2 > 0.96). For reference, whole Puzzle construct EY based on unconfined compression
was was 0.27±0.03 MPa and G* was 1.2±0.2 MPa (n = 4). On day 0, the cell-seeded
hydrogel had EY=9.2±1.2 kPa and G*=47±3 kPa (n = 3). GAG content and collagen
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Figure 5.5: Experimental Flowcharts. (A) Engineering of puzzle-shaped constructs
(5.3.1): Puzzle and Square constructs cultured individually for 28 days. This experi-
ment was repeated independently (Studies 1 and 2). (B) Assembly of puzzle-shaped
constructs (5.4.1): Day 49 Evaluation of: Puzzle constructs assembled on day 28; Fresh
constructs assembled on Day 49; and Square construct controls. Puzzle and Square
constructs stem from Studies 1 and 2; Fresh constructs stem from Study 1. All as-
semblies are 3×3. (C) Integration techniques for assembled puzzle-shaped constructs
(5.5.1): Puzzle constructs assembled on day 28 evaluated at days 49 and 63 (Extended
Puzzle); Fresh constructs assembled and evaluated on day 49; and Square construct
controls evaluated on days 49 and 63 (Extended Square). All assemblies are 2×2. All
constructs stem from Study 1.
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content were significantly higher for Puzzle constructs normalized to WW, DW, and
DNA (p < 0.001, Fig. 5.6C-D). Histology confirmed quantitative biochemical assays
and gross morphological appearance. GAG and collagen were distributed more consis-
tently throughout the Puzzle constructs than the respective Square control constructs
(Fig. 5.6E-F). Viability staining confirmed viability of both groups (not shown).
In the independent repeat study of the above (Study 2), similar results were ob-
served. Here, Puzzle constructs achieved EY=0.12±0.02 MPa and G*=0.62±0.10 MPa
(n = 7) from an initial day 0 level of EY=5.0±3.1 kPa and G*=40±10 kPa (n = 3). In-
dentation showed centers of Puzzle constructs as having a 3.8X greater EY than Square
constructs (p < 0.05; fit R2 > 0.82; Puzzle: n = 6; Square: n = 4). GAG/WW and
GAG/DNA were significantly higher for Puzzle than Square constructs (p < 0.001).
Collagen content was significantly higher for Puzzle constructs than square constructs
across all normalizations (p < 0.001). Gross morphology also showed consistent opacity
in Puzzle constructs and increased peripheral opacity in Square constructs.
5.4 Assembly of Puzzle Shaped Grafts
5.4.1 Methods
Following 28 days of culture, Puzzle constructs were assembled in a 3×3 arrangement
of 9 subunits (Fig. 5.1). These assemblies and the large Square controls were cultured
for an additional 21 days (Fig. 5.5B).
On day 49, Square and assembled Puzzle constructs were evaluated for functionality
using compression to failure (2.1.5.4). ETF values were normalized by tissue volume.
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Figure 5.6: Puzzle strategy: effects of individual culture
(A) Gross morphology at day 28. (B) local EY, (Puzzle: n = 5; Square: n = 3;
p < 0.05); (C) GAG content per wet weight, (Puzzle: n = 8; Square: n = 3; p < 0.001);
(D) Collagen (COL) content per wet weight (Puzzle: n = 9; Square: n = 3; p < 0.001).
(E) Safranin O/Fast Green staining for GAG visualization (Puzzle: n = 2; Square:
n = 1); (F) Picrosirius Red staining for collagen visualization (Puzzle: n = 2; Square:
n = 1); Solid blue bars: Puzzle; Hatched gray bars: Square. All scale bars: 1 mm.
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Surface area for calculating tissue volume was measured in ImageJ. Groups are refer-
enced as “Puzzle,” “Square,” and “Fresh.” Viability (2.1.5.6) and histology (2.1.5.7) of
assembled Puzzle constructs were also assessed as in 5.3.1.
Statistical analyses were performed as described in 2.1.6.
5.4.2 Results
Puzzle constructs could be assembled successfully on day 28 despite their growth (Fig.
5.7A). On day 49, assembled Puzzle constructs appeared opaque throughout (Fig.
5.7B). Data from the Puzzle and Square groups was pooled from the two indepen-
dent studies. Data for the Fresh group stems from one study (Study 1). In the repeat
study showing greater tissue growth (Study 1), square constructs developed an internal
fluid-filled region or sac due to osmotic swelling of proteoglycans and reduced collagen
deposition at the center of the construct (Fig. 5.7C).
Failure testing showed no significant differences in ETF across groups (Fig. 5.7D),
however failure modes varied across groups (Fig. 5.7E). Puzzle and Fresh groups failed
by a combination of tearing and separating. In many cases, the subunits that sepa-
rated suffered minimal damage. Tearing was not limited to the “male” portion of the
Puzzle constructs. Square constructs without fluid-filled sacs failed by tearing. Square
constructs with the sacs failed as the sac burst, releasing fluid, and then eventually
tore.
Assembled Puzzle constructs contained viable cells throughout (Fig. 5.8A). His-
tological analysis showed intense staining throughout the assembled construct (Fig.
5.8B-C). Collagen staining appeared more intense at the borders between Puzzle con-
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Figure 5.7: (A) Photo of Puzzle constructs assembled and placed in culture at Day
28. (B) Gross morphology assembled 3×3 arrangement of 9 subunit Puzzle pieces at
Day 49 (28 days individual + 21 days assembled culture). Scale bar: 1 mm; (C) Gross
morphology of Square construct showing a fluid-filled sac (marked by dotted white
arrows). (D) Energy to Failure (Puzzle: n = 9; Square: n = 6; Fresh: n = 3; no
statistically significant difference; Puzzle and Square groups contain values from two
independent studies, Fresh group contains values from one study). (E) Representative
images of puzzle, square, and fresh constructs at the start strain, the failure strain,
and a strain past failure. Failure of the square construct is shown in the case of with
(right) and without (left) fluid filled sacs. Constructs speckled with Verhoeff stain
for visualization; Solid yellow arrows mark areas of tearing. Dotted pink arrows mark




Figure 5.8: (A-B) Viability image of surface (A) and cross-section (B) of 3×3 puzzle
arrangement at day 49. C-D. Cross-sectional histology of assembled 3×3 puzzle arrange-
ment at day 49: Safranin O/Fast Green for GAG visualization (C) and Picrosirius Red
for collagen visualization (D). (n = 1). Scale bars: 1 mm. LIVE/DEAD® images
provided to clarify orientation of histological sections.
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5.5 Integration Techniques for Assembled Puzzle-
Shaped Grafts
5.5.1 Methods
In an additional series of tests, Puzzle and Square constructs were generated as de-
scribed in 5.3.1 and cultured for 28 days to investigate scenarios for increasing inte-
gration strength between assembled pieces (Fig. 5.5C). For this evaluation, assembled
Puzzle constructs with a 2×2 arrangement and respective Square constructs of similar
size were studied. Three experiments were performed: (1) as described in 5.4.1, Puzzle
constructs were assembled on day 28 followed by culturing the assembly for an addi-
tional 21 days (Day 49) - “Puzzle”; (2) Puzzle constructs were maintained separately
in culture and then assembled together fresh on day 49 - “Fresh”; and (3) a group of
constructs assembled on day 28 was cultured for another 35 days (until Day 63) - “Ex-
tended Puzzle.” At the end of the experiment, each puzzle construct group and their
respective square control (“Square” and “Extended Square”) were evaluated via failure
testing (2.1.5.4). Puzzle, Square, Fresh, and Extended Puzzle groups were evaluated
histologically (5.3.1).
Statistical analyses were performed as described in 2.1.6.
5.5.2 Results
Here, all Square constructs (cast in Study 1) contained the aforementioned fluid-filled
sacs past day 28 culture. Compared to the assembled Puzzle group, Square and Ex-
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tended Square constructs failed at a significantly lower energy (p < 0.001, Fig. 5.9A).
The Fresh and Extended Puzzle groups failed at a significantly higher energy than the
Puzzle group (p < 0.05) and the two square groups (p < 0.001). Similar to the larger
constructs with fluid-filled sacs described in 5.4.2, the Square and Extended Square
groups failed by “bursting,” releasing internal fluid, and then eventually tearing (Fig.
5.9B). Puzzle, Fresh and Extended Puzzle constructs failed by a combination of tearing
along with some subunit separation.
Figure 5.9: (A) Energy to Failure (n = 3). * indicates significant difference from the
Puzzle Group (p < 0.05), ˆ indicates significant difference from the square group (p <
0.001). Puzzle, fresh, and square groups evaluated on Day 49. Extended Puzzle and
Extended Square groups evaluated on Day 63. (B) Representative images of constructs
at the start and the failure points. An image of a point past failure is also included to
emphasize failure mode. Solid yellow arrows show areas of tearing. Dotted pink arrow
show areas of separation. Blue @ symbols indicate fluid release from the construct.
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As seen at day 28 (5.3.1, Fig. 5.6E-F), staining for GAG and collagen in the Square
constructs was more intense towards the construct periphery (Fig. 5.10). The Puzzle
and Extended Puzzle groups showed more consistent staining throughout the construct
cross-section. Collagen staining appeared more intense at the periphery of each subunit.
Likewise, staining of individual Fresh constructs showed consistent staining throughout
the cross-section similar to the individual constructs shown in Fig. 5.6E-F.
Figure 5.10: (A-B) Cross-sectional histology of assembled 2×2 puzzle arrangement at
D49: Safranin O/Fast Green for GAG visualization (A) and Picrosirius Red for collagen
visualization (B). (Puzzle, Square, Extended Puzzle: n = 1; Fresh: n = 2). Puzzle,
Square, and Fresh groups were evaluated on day 49, while the Extended Puzzle group
was evaluated on day 63. Scale bars: 1 mm. * indicates gaps between or within
(“female” portion) subunits, ˆ indicates area inside the fluid-filled sac.
5.6 Evaluation of Biocompatibility
5.6.1 Methods
Pairs of puzzle constructs (n = 4 pairs) cultured for 42 days were assembled and
implanted subcutaneously in the dorsum of nude mice (n = 2) for 28 days. Mice were
sacrificed on day 28, implants were harvested and assessed grossly and histologically
and complete necropsy was performed on each mouse. All research was approved by
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the University of Missouri Institutional Animal Care and Use Committee.
5.6.2 Results
All puzzle constructs remained assembled and intact in mice for the 28-day study du-
ration (Fig. 5.11). Complete necropsy showed no gross or histologic pathology in any
tissues, including liver, kidney, brain, or bone marrow. Retrieved pairs of puzzle pieces
showed preserved viability and phenotype in each construct with histologic evidence for
fusion between individual pieces. Constructs were joined by fibrovascular tissue with
low to moderate cellularity, comprised primarily of mesenchymal and fibroblastic cells.
Figure 5.11: Two pairs of puzzle constructs implanted subcutaneously in the dorsum
of nude mice (left) and retrieved (right). Scale bar shows mm.
5.7 Discussion
Overcoming diffusional limitations to scale up the size of engineered articular cartilage
constructs remains a critical challenge for clinical translation.
The preliminary concentric circle study study showed benefit of individual culture
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(Fig. 5.3B). However, assembling subunits at day 14, originally chosen to coincide with
growth factor release, may have been too early;. The placement of the stiff outer ring
likely confined the construct, preventing the swelling seen in the controls, hindering nu-
trient transport, and allowing controls to “catch up” in tissue properties. Still, increased
collagen content was seen (Fig. 5.3C), mostly lying between subunits (Fig. 5.4A), likely
holding these constructs together with excellent integration strength [DiMicco and Sah,
2001]. These results led to the 28-day individual culture period in the puzzle study.
The puzzle piece strategy described here shows promise as a relatively simple tech-
nique to address the diffusion problem. The technique inverts the channel concept;
rather than introducing additional nutrient pathways into a large engineered tissue,
it maintains short nutrient pathways in culture, followed by assembly and integration
once the subunits are functional.
In concept, filling a large defect with multiple small grafts is most similar to osteo-
chondral autografting such as mosaicplasty, in which multiple cylindrical autografts are
harvested from a low weight bearing region, then arrayed to fill defect [Hangody and
Baló, 2011, Robert, 2011]. Mosaicplasty is difficult to perform, and though maximum
coverage of the defect is desired, the technique is often associated with dead space be-
tween cylindrical grafts. This gap space can be minimized by utilizing grafts of varying
sizes or filled with a bone paste [Hangody and Baló, 2011, Robert, 2011]. In this con-
text, an interlocking engineered graft system would offer near 100% coverage without
the aforementioned donor site morbidity associated with autograft procedures.
Culturing large constructs in static, free-swelling conditions results in tissues with
central regions lacking consistent biochemical content, strength, and functional me-
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chanical properties (Fig. 5.6). The disparity between the central and peripheral tissue
properties, especially in the case of rapid growth, can lead to undesired effects. Bian
et al. reported cracking at the center of constructs cast at high cell seeding density,
positing the effect was due to GAG-induced osmotic swelling forces in constructs with
disproportional peripheral and central collagen content [Bian et al., 2009a]. Here the
effect was amplified in the Square constructs (both sizes), which in one of the two
batches of constructs developed an internal separation at the center, which then filled
with fluid (Fig. 5.7C). As expected, culturing small subunits minimizes the radial dis-
parity in properties (Fig. 5.6). Puzzle constructs punched from the same cell-seeded
gel slabs did not develop such cracks. It is expected that mechanical and biochemical
functionality would be further increased by engineering even smaller puzzle subunits
(here puzzle tissue volume was similar to that of a 6 mm diameter disk, larger than
the commonly utilized 4 mm diameter disk adopted in our laboratory [Kelly et al.,
2008, Lima et al., 2008b, Ng et al., 2008a, Nover et al., 2015e, Nover et al., 2015c]. As-
sembling the subunits yields a large tissue with more radially consistent GAG and
collagen distribution (Fig. 5.8C-D).
The mechanical integrity of assembled puzzle constructs was evaluated using a novel
test, which compressed tissues to failure with a convex, yet highly congruent lens.
This test was utilized to acquire an understanding of how the large engineered tissue
constructs would fare under physiologic conditions without the shouldering of loads
by surrounding native tissue. Evaluation of functionality is important, especially since
there may be concerns of tissue filling in the holes and stress concentrations in channeled
constructs [Nims et al., 2015].
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In the current study, assembled puzzle constructs were able to withstand large
strains before failure. Assembled groups of nine puzzle constructs failed at a central
strain (maximum strain located at the center of the lens) of 50±9% strain (n = 9) and
assembled groups of four puzzle constructs failed at a central strain of 40±5%, which
is similar to the failure strain of stronger, smaller constructs reported by Tan et al.
using a flat platen, both at 0.3% strain/s [Tan et al., 2010]. For reference, Park et
al. applied dynamic loading at physiologic stress levels to native cartilage, measuring
peak compressive strain amplitudes as 15.8±3.4% at 0.1 Hz and 12.7±2.3% at 1 Hz,
and reporting curve-fit functions for relating stress and strain [Park et al., 2004]. Inte-
grating these functions from 0% to these strain amplitudes yields mean energies of 0.42
mJ/mm3 at 0.1 Hz and 0.26 mJ/mm3 at 1 Hz. In other words, normal physiological
loading requires articular cartilage to withstand these levels of stored strain energy den-
sity without failure. The ETF of the assembled Puzzle constructs is within one eighth of
these values, which represents an encouraging outcome for this first proof-of-principle,
suggesting that future enhancements in individual puzzle properties and puzzle integra-
tion may realistically lead to graft survival. As reported in previous studies using this
chondrocyte-seeded agarose system [Hung et al., 2004,O’Connell et al., 2014], GAG lev-
els achieved in the constructs (Fig. 5.6C) are comparable to native levels in the bovine
cartilage from which chondrocytes are harvested, whereas collagen levels (Fig. 5.6D)
remain at one-tenth of the native level. Therefore, strategies that enhance synthesized
collagen content will likely be highly beneficial for this puzzle assembly strategy.
In this study, assembled puzzle constructs fail through a combination of tearing and
separation, which in many instances leaves separated subunits relatively undamaged
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(Fig. 5.7 & Fig. 5.9). The overall functionality of these assembled constructs may
be linked to the strength of the individual subunits, their junctions, and attachment
between pieces. These puzzle assemblies show a significant advantage over the squares
whenever those developed fluid-filled sacs (Fig. 5.9). No advantage was apparent when
this phenomenon did not occur (Fig. 5.7); despite the weak central region of squares,
their border of elaborated matrix seems to hold the large tissues together until a tear
propagates outward.
Integration of puzzle constructs may be augmented by a variety of methods. Here,
extending the culture of assembled constructs showed a clear advantage in failure prop-
erties (Fig. 5.7). Allowing for increased individual subunit culture time prior to assem-
bly provided mixed results, failing at significantly higher energy in one study (Fig. 5.9)
and at a similar energy in the other (Fig. 5.7). Subunit integration may also be ampli-
fied by caulking the assembled pieces using cell-seeded agarose, fibrin glue, or another
biocompatible tissue adhesive [Cascio and Sharma, 2008,Englert et al., 2007,Jürgensen
et al., 1997,Sargeant et al., 2012,Sitterle et al., 2009,Wang et al., 2007]. Additionally,
it is expected that the incorporation of strong, interlocking, porous bases (such as pre-
viously described by our laboratory [Lima et al., 2008a, Nover et al., 2015c], Chapter
3) into the underside of puzzle subunits may further prevent separation (Fig. 5.12A).
Fusion of subunits may also be facilitated post implantation in vivo. Computational
modeling may be used to guide alterations to the interlocking puzzle shape for improved
growth and junctional integration [Nims et al., 2015].
Further studies are required to determine the optimal strategy for puzzle implanta-
tion. It is envisioned that puzzle subunits could be cultured individually, then assembled
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Figure 5.12: A. Demonstration of acellular osteochondral Puzzle Constructs cast on
3D printed interlocking porous bases: side-view of individual osteochondral construct
consisting of (a) gel-region and (b) bone-region (left); paired osteochondral constructs
(center); assembly of nine bases (right). Scale bars: 1 mm. B. Demonstration of in
situ assembly and trimming of puzzle constructs (42 days cultured) in a canine cadaver
femur defect.
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and trimmed [Tan et al., 2010] in situ via open joint surgery (Fig. 5.12B), as currently
done for cartilage resurfacing of large defects, or potentially arthroscopically based on
the ability to deliver individual pieces to the defect. Alternatively, puzzle constructs
could also be cultured, assembled, and then subpunched to the desired defect size.
Porous bases could be incorporated, as mentioned above, for anchoring and meshing
with the underlying bone, which would require an additional shapes to cap or plug the
“male” and “female” parts of the puzzle shape or trimming if permitted by the base
material. Ideally, a large anatomically curved articular surface [Hung et al., 2003,Roach
et al., 2015] could be assembled from interlocking engineered subunits, then sealed with
a bioadhesive.
In summary, the puzzle assembly strategy offers a promising option for circumvent-
ing the limitations of nutrient diffusion in the generation of large engineered cartilage
grafts. It is anticipated that this strategy could be utilized in the engineering of other
tissues as well as combined with other complementary culture strategies.
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Articular cartilage defects greater than 2 cm2 are often treated with osteochondral
allografts. While fresh grafts have been shown to result in long-term functional out-
comes [Gross et al., 2008], success is a function of the viability of the graft’s chondro-
cytes, which diminishes over storage time [Gross et al., 2008,Beaver et al., 1992,Bakay
et al., 1998, Pallante et al., 2012] leading surgeons to consider 28 days post-harvest as
the limit for the optimal transplantation window. Current mandatory disease testing
of fresh grafts takes at least 14 days, which limits graft availability for clinical use to 14
days or less [Sherman et al., 2014]. Current tissue bank storage protocols entail grafts
being stored in serum-containing media in refrigeration (4 ◦C) [Williams et al., 2004].
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Based on the limitations of current storage protocols with respect to graft availabil-
ity, researchers are investigating various methods of storage in an attempt to increase
the duration of this storage window [Williams et al., 2004, Teng et al., 2008, Csönge
et al., 2002, Ball et al., 2004, Bian et al., 2010b, LaPrade et al., 2009, Williams et al.,
2007]. A preservation system recently developed by Stoker et al., called the Missouri
Osteochondral Allograft Preservation System (MOPS), has shown maintenance of day
0 chondrocyte viability for at least 63 days without the use of serum, growth factors, or
refrigeration [Stoker et al., 2012,Cook et al., 2014b]. This preservation system reduces
concerns associated with xenogenic media components and simplifies storage logistics.
Still, as previously mentioned, osteochondral allografts are in insufficient supply to
meet clinical demand [Paige and Vacanti, 1995, Mow et al., 1991, Langer and Vacanti,
1993], so tissue engineering may offer an alternative, cell-based strategy for fabricat-
ing biomimetic grafts [Hung et al., 2004]. To facilitate eventual clinical translation,
engineered grafts will also require an effective preservation/storage protocol, in order
to give the product a “shelf-life” [Griffith and Naughton, 2002]. As native and engi-
neered cartilage differ in structure and composition, preservation requirements of the
tissues may also differ. Previous studies in our laboratory have shown that engineered
tissues grown with adult cells require culture media supplementation with TGF-β3 for
development and maintenance of tissue properties [Ng et al., 2010,Bian et al., 2007,Ng
et al., 2008b]. Cessation of growth factor administration after 14 days (e.g., transient
growth factor exposure), an effective protocol for promoting functional development of
engineered constructs derived from juvenile chondrocytes [Ng et al., 2008b, Ng et al.,
2011, Lima et al., 2007, Byers et al., 2008], was shown to decrease Young’s modulus of
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mature-cell constructs to ˜15% of original values in only 2 weeks (day 28 of culture) [Ng
et al., 2008b]. As the MOPS system does not include TGF-β3, we speculated that en-
gineered tissues would exhibit a similar loss of tissue properties under the prescribed
preservation conditions.
In the current study, MOPS preservation of tissue engineered cartilage grafts, cul-
tivated to native mechanical properties, was investigated to determine its suitability
for this purpose. We explored its efficacy by comparing grafts maintained in culture
as well as at room temperature and cold storage. While the immediate focus of this
evaluation was on the critical clinical window of 28 days, preservation up to 56 days
was investigated to explore the potential for longer-term storage. Constructs were eval-
uated for mechanical, biochemical, histological, gross, and viability properties. Tissue
properties were compared to those at the point of maturation and compared to the
other experimental groups at each time point.
6.2 Preservation/Storage with MOPS
MOPS was investigated as a preservation/storage protocol for mature engineered car-
tilage tissues. Temperature dependence was investigated by utilizing MOPS at 4 ◦C.




P1 or P2 canine constructs of 4.0 mm diameter and 2.3 mm thickness were fabricated as
described in 2.1.1. Constructs were cultured according to 2.1.2 with medium changed
three times per week. Constructs were evaluated biweekly for mechanical (2.1.5.1),
biochemical (2.1.5.5), histological (2.1.5.7), and viability (2.1.5.6) properties.
Once constructs reached maturity (28-42 days), judged by an average EYin the
native range (>200 kPa, [Ng et al., 2010]), constructs were randomly assigned to exper-
imental groups: MOPS-25, standard preservation in MOPS media at room temperature
(25 ◦C, as described in 2.1.4); MOPS-4, preservation in MOPS media with refrigera-
tion (4 ◦C); or continuous culture conditions (2.1.2). For constructs in MOPS media,
the media were changed once per week. The maturity point served as the baseline for
preservation. Culture and preservation of experimental groups is summarized in Fig.
6.1.
Constructs were evaluated at the baseline and 14, 28 and 56 days preserved, in-
vestigating preservation during the current 28 day clinical window and its extension.
Constructs were evaluated for mechanical (2.1.5.1), biochemical (2.1.5.5), histological
(2.1.5.7), and viability (2.1.5.6) properties. For all biochemical time points besides day
0 (initial casting) full constructs were utilized.
Statistical analyses were conducted as described in 2.1.6. Separate studies compar-
ing MOPS-25 to continued culture control and comparing MOPS-25 to MOPS-4 were
run and repeated (MOPS-25: 4 individual runs; MOPS-4, Continued Culture: 2 indi-
vidual runs). For easy visualization and cross-study analysis, results from each study
were normalized to the respective maturity point average value, then pooled.
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Figure 6.1: Schematic of experimental group conditions in the documented studies.
Maturity was judged by EY>200 kPa.
6.2.2 Results
Constructs reached maturity (>200 kPa) in 28-42 days, providing a baseline for preser-
vation. Averaged across the four studies, the maturity point tissue properties were:
EY=258±23 kPa, G*=1.68±0.09 MPa, GAG=1.97±0.06 mg (4.93±0.17% wet weight),
and collagen= 0.70±0.05 mg (1.73±0.13% wet weight). Following this maturity point,
the constructs were split into the experimental groups. Time points refer to the days
post-maturity, either stored/preserved or kept in culture.
At the end of the critical clinical window of 28 days, the MOPS-25 protocol main-
tained 74.7±15.1% of EY, 83.2±16.6% of G*, 88.6±15.6% of the total GAG content,
and 89.1±14.7% of the total collagen content averaged across four independent stud-
ies (Fig. 6.2). In that window, GAG and collagen content did not drop significantly,
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whereas EY and G* were significantly lower than the maturity point. Viability staining
showed the majority of cells to be viable following 28 days of preservation (Fig. 6.3A-
B). MTT data showed the metabolic activity decreased over time, with 56.2±17.1% of
baseline metabolic activity at 28 days of storage (Fig. 6.3C).
Figure 6.2: (A) Young’s Modulus (n = 23 − 25), (B) Dynamic Modulus (n = 24 − 25),
(C) GAG Content (n = 17 − 19), and (D) Collagen Content (n = 16 − 21) normalized
to respective maturity point tissue properties (n = 26 − 32), and averaged across four
independent studies for samples preserved for 14 and 28 days with MOPS-25. ˆ indicates
significant difference from maturity point (p < 0.05).
Continuing culture of constructs led to significantly decreased EY at 14 days past
maturity, which was insignificantly lower than the maturity point at 28 days past ma-
turity (Fig. 6.4). However, G* and total GAG content increased significantly over
the maturity point and the preserved groups (Fig. 6.4). Total collagen content also in-
creased, becoming significantly different than the preserved groups (Fig. 6.4). Viability
was not different from MOPS preservation (Fig 6.3A).
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Figure 6.3: Representative cross-sectional LIVE/DEAD® images comparing MOPS-25
to Continued Culture and Maturity Point (A) and comparing MOPS-25 to MOPS-4
and Maturity Point (B) at 28 preserved (n = 2 − 4). MTT absorbance values after
28 days preserved normalized to maturity point values (C). MTT values for MOPS-25
are pooled from 3 independent studies (n = 12), values for CC are from 1 independent
study (n = 3), and values for MOPS-4 are pooled from 2 independent studies (n = 8).
Maturity point data pooled from 3 independent studies (n = 14). ˆ indicates significant
difference from maturity point (p < 0.05). There is no significant difference between
groups.
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MOPS-4 showed no difference compared to MOPS-25 in the first 28 days (Fig. 6.4).
Viability and metabolism were not different from MOPS preservation (Fig 6.3B-C).
Figure 6.4: (A) Young’s Modulus (n = 10 − 25), (B) Dynamic Modulus (n = 10 − 25),
(C) GAG Content (n = 9 − 19) , and Collagen Content (n = 9 − 21) normalized to
respective maturity point tissue properties (n = 26 − 32), and averaged across 2 (Con-
tinued Culture, MOPS-4) or 4 (MOPS-25) independent studies for samples preserved
for 14 and 28 days with. ˆ indicates significant difference from maturity point and
letters indicate significantly different groups (p < 0.05).
Past the 28-day clinical window, all construct properties decreased. At 56 days,
constructs preserved with MOPS-25 fell to 43.4±13.1% of EY, 55.9±16.6% of G* yet
maintained 74.1±14.5% of GAG and 86.7±19.3% of collagen (Fig. 6.5). Here, refrig-
eration retained significantly more GAG, leading to a significantly higher EY than the
MOPS-25. In each study, GAG measured in the media was generally higher for MOPS-
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25 preserved constructs than MOPS-4 (data not shown). Continuing culture also led to
a drop in EY, yet at 56 days past maturity G*, GAG content, and collagen content were
all higher than at the maturity point. In preserved groups, the change in Young’s and
dynamic moduli were significantly lower than the maturity point. GAG content was
significantly lower for MOPS-25 samples and significantly higher for continued culture
samples compared to the maturity point. Collagen levels were not significantly differ-
ent from the maturity point at 56 days past maturity. Additionally, metabolism was
significantly higher for continuous culture than preserved groups (Fig. 6.6). Histology
(not shown) corroborated trends ascertained through assays.
6.3 Discussion
As the field of articular cartilage tissue engineering advances, it will require an effective
storage/preservation protocol to give fabricated replacement tissues a “shelf-life” prior
to transplantation, allowing for proper translation into clinical use. Currently, the op-
timal transplantation window for organ donor osteochondral allografts effectively ends
at 28 days post-procurement due to decreasing chondrocyte viability [Sherman et al.,
2014]. As such, a storage protocol for engineered tissues should maintain properties for
at least 28 days. As the MOPS protocol has been shown to maintain allograft viabil-
ity for at least 63 days (35 day extension of the clinical transplantation window) with
logistical, chemical, and financial benefits [Stoker et al., 2012, Cook et al., 2014b], it
was adopted as a starting point for preservation of engineered grafts. The properties at
construct maturity point (when preservation was initiated) were used as baseline from
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Figure 6.5: (A) Young’s Modulus (n = 12 − 30), (B) Dynamic Modulus (n = 12 − 31),
(C) GAG Content (n = 8 − 28), and (D) Collagen Content (n = 9 − 26) normalized to
respective maturity point tissue properties (n = 26 − 32), and averaged across 2 (Con-
tinued Culture, MOPS-4) or 4 (MOPS-25) independent studies for samples preserved
for 56 days with. ˆ indicates significant difference from maturity point, letters and *
indicate significantly different groups (p < 0.05).
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Figure 6.6:
(A) Representative cross-sectional LIVE/DEAD® images comparing MOPS-25 to Con-
tinued Culture and Maturity Point and (B) comparing MOPS-25 to MOPS-4 and Ma-
turity Point at 56 days preserved (n = 2 − 4). (C) MTT absorbance values after 56
days preserved normalized to maturity point values. MTT values for MOPS-25 are
pooled from 3 independent studies (n = 11), values for CC are from 1 independent
study (n = 4), and values for MOPS-4 are pooled from 2 independent studies (n = 8).
Maturity point data pooled from 3 independent studies (n = 14). ˆ indicates significant
difference from maturity point (p < 0.05). There is no significant difference between
groups.
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which relative changes in tissue properties could be assessed. As another point of com-
parison, a tissue culture group was added, representing an alternative scenario in which
grafts would be maintained in tissue culture until implantation. Additionally, altering
the MOPS temperature to 4 ◦C served to investigate the influence of temperature.
Contrary to our experience growing engineered cartilage derived from adult chondro-
cytes that demonstrated a dramatic drop (to ˜15% of initial values) in tissue properties
upon withdrawal of growth factor supplementation of the media [Ng et al., 2008b], ap-
plication of growth factor-free MOPS to mature tissue engineered cartilage was observed
to maintain most tissue properties within the critical clinical window, with mostly vi-
able cells after 28 days (Fig. 6.3). EY and G* dropped significantly to 70% of their
value at the maturity point. Still, GAG and collagen content were not significantly
changed from the maturity point (Fig. 6.2). While metabolism decreased, this is com-
mon for grafts stored under sub-physiologic temperatures [Pylawka et al., 2008]. These
encouraging results suggest that MOPS has potential for storing engineered cartilage
for up to 28 days.
Whereas MOPS has shown to extend maintenance of native canine allografts to 63
days of storage 14, it did not provide similar results with engineered tissues. At 56
days of storage, EY, G*, and GAG content were significantly lower than their maturity
point values, though collagen content remained insignificantly changed (Fig. 6.5). At
56 days preserved, chondrocyte viability decreased, yet still displayed viable cells in
each independent study (Fig. 6.3 & 6.6). In samples preserved for 56 days (Fig. 6.6),
viability staining revealed an unusual pattern consisting of brightly stained dead cells
on the immediate periphery, brightly stained live cells in the center, and a mix of dead
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cells and dimly stained live cells in between. This pattern may be related to suscepti-
bility of the phenotype to pathology, the breakdown of extracellular matrix, a chemical
factor released by the cells into the media, and/or the lower than physiologic storage
temperature. Future studies will investigate the cause of this unique arrangement.
In terms of temperature, refrigeration was insignificantly different than room tem-
perature at 28 days preserved. However, temperature may be more important with
longer storage times, as refrigeration led to EY and GAG content that was significantly
higher than MOPS-25 at 56 days preserved (Fig. 6.4-6.5). The GAG content in the
media implies decreased turnover and metabolism in refrigerated samples. Starting
when placed in preservation conditions, engineered tissues decrease in metabolic ac-
tivity over time as the properties slowly decrease, until the cells are quiescent. These
results indicate that refrigeration is preferred for the storage of tissue engineered grafts,
retaining tissue properties for a longer period of time. However, within the 28 day clin-
ical transplant window, room temperature storage may be satisfactory, and logistically
easier.
These studies have several limitations. While the adult canine model is an excellent
preclinical transplantation model [Ng et al., 2010, Gregory et al., 2012, Ahern et al.,
2009,Cook et al., 2014a], it still does not exactly replicate the adult human clinical sit-
uation. However, repeated success culturing canine chondrocytes in agarose to native
or near-native properties [Ng et al., 2010, Bian et al., 2010a, Kelly et al., 2013] makes
it a robust model system for the current studies. Similarly, these studies are purely
in vitro, aiming to maintain tissue properties over time. An in vivo study would be
required to fully understand how preserved engineered grafts will fare after transplan-
117
tation. The continued culture group presented for reference is not a realistic clinical
scenario: it requires greater cost and labor (3X weekly media change with growth
factor supplementation, incubation), and would still require storage during manda-
tory disease/contamination screening. Nevertheless, this is a valuable reference point,
providing knowledge of tissue properties past maturity which may plateau or decline
without additional stimulation, such as dynamic loading [Bian et al., 2010a]. Addition-
ally, unlike clinical allografts, the tissue engineered constructs in these studies are not
osteochondral; however, even for clinical allografts, the bone portion is treated as non-
living [Görtz and Bugbee, 2006], and so it is believed that the results of these studies,
preserving chondral-only engineered grafts will be applicable to preserving tissue en-
gineered osteochondral grafts, which, likewise, incorporate nonliving bone or bone-like
regions [Lima et al., 2008a].
While, to our knowledge, no literature currently exists concerning the storage of tis-
sue engineered cartilage grafts, there have been many clinical and basic science studies
assessing stored grafts in vivo [Pallante et al., 2012, Bakay et al., 1998, LaPrade et al.,
2009, Williams et al., 2007, Cook et al., 2014b, Malinin et al., 2006, Ranawat et al.,
2008, Shasha et al., 2003] and in vitro [Williams et al., 2004, Teng et al., 2008, Csönge
et al., 2002, Ball et al., 2004, Bian et al., 2010b, Stoker et al., 2012, Pylawka et al.,
2008, Malinin et al., 2006, Williams et al., 2005, Williams et al., 2003, Rohde et al.,
2004, Pallante et al., 2009, Kwan et al., 1989, Garrity et al., 2012, Allen et al., 2005]
using a variety of storage protocols and evaluation methods. Most commonly, chondro-
cyte viability is used as the marker of allograft success 3, yet ideally tissue properties
best match freshly harvested tissues, which have been shown to have maximum viabil-
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ity and long-term implantation success [Gross et al., 2008, Sherman et al., 2014, Görtz
and Bugbee, 2006]. Tissue engineering studies allow for the fabrication of a high quan-
tity of parallel samples, allowing for consistent evaluation of tissue properties. These
comprehensive measurements demonstrate that MOPS can maintain the majority of
tissue properties over 28 days of storage, though further optimization is needed to
achieve full tissue maintenance through 28 days and beyond. Looking forward, we con-
ceive of the ability to screen cells/constructs during construct fabrication/culturing pe-
riod as is done routinely for commercially-available engineered skin [Hansbrough et al.,
1997,Lanza et al., 2014,Hart et al., 2012,Muhart et al., 1999]. In this scenario, MOPS
would further increase the clinical shelf-life of engineered OC allografts, starting at the
“day 0” of target mature properties. The disparate preservation response of native
and engineered cartilage to MOPS may ultimately reflect inherent differences between
chondrocytes residing in situ and those manipulated in culture, and directed toward de
novo tissue formation. Future studies will include alterations of the storage protocol to
decrease degradation and an in vivo study to ensure the translational efficacy of stored
engineered grafts.
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Chapter 7
Conclusions & Future Directions
7.1 Conclusions
The purpose of this dissertation was to explore strategies for increasing the translational
potential of engineered grafts by better mimicking native osteochondral allografts [Hung
et al., 2004,Lima et al., 2008a]. Each hypothesis (1.1) was accepted, indicating that each
strategy has been proven feasible. Conclusions drawn from each researched approach
are briefly summarized below. Following these conclusions, future research directions
of each research project are discussed, focusing on the further optimization of these
strategies. Finally, these strategies and additional challenges in engineering functional
biomimetic osteochondral grafts are synthesized and discussed.
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7.1.1 Fabrication and Characterization of Tissue Engineered
Osteochondral Grafts
Porous titanium supports robust cartilage growth, making it a viable bone-like base
material for the fabrication of engineered osteochondral tissue constructs, a clinically
relevant alternative to allografts (Chapter 3). The selective laser melting technique used
to fabricate the bases offers exceptional control over the structure of the base, which
may allow for the fabrication of grafts with anatomic shape and curvature [Roach et al.,
2015,Hung et al., 2003] and tailoring of pore structure for optimal chondral growth and
osteointegration [Mullen et al., 2009,Mullen et al., 2010,Stamp et al., 2009,Bobyn et al.,
1980]. PCL may offer an alternative to metals in engineered OC grafts; we also show
that PCL bases can be used in the same way.
We found that increasing base pore size diminishes measured mechanical properties
of the chondral region. Such an understanding of base-gel interactions is critical for
fabricating engineered grafts that function like native ones.
7.1.2 Focused Ultrasound Approach for Local Tissue Property
Modulation
The studies described in Chapter 4 display proof-of-principle of HIFU as a method-
ology for altering local tissue properties within cartilage tissue engineering relevant
constructs. Namely, we show that we can apply HIFU in a sterile manner to cartilage
tissue engineering relevant hydrogels with incorporated albumin, generating decreased
transport in these regions. Over time, concomitant cell death remains localized to the
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point of treatment, indicating that this undesired effect may be balanced by benefi-
cial tissue property changes. Such a technology is especially promising for generating
biomimetic tissue interfaces, and may have other applications in translating engineered
tissues to the clinic.
7.1.3 Strategies for Scaling Up
Engineering small, interlocking tissues proves a feasible method for generating large
engineered tissues (Chapter 5). This method circumvents the diffusional laws that cause
culturing large cell-seeded gels to yield inconsistent, nonfunctional tissues. Studies show
that increased subunit strength and increased assembled culture time lead to increased
assembled graft functionality. This method can be used to cover large defects of variable
size. Additionally, it is expected that this strategy for overcoming diffusional limitations
can be utilized in conjunction with others.
7.1.4 Preservation/Storage of Engineered Grafts
The studies described in this chapter represent the first reported attempt to maintain
engineered tissue properties in storage (Chapter 6). The results promote MOPS as
a satisfactory protocol for 28 days of storage, though modifications may be required
to increase that window. Though an OC base is not incorporated in the constructs
preserved in these studies, it is expected that, since this base is nonviable, the results
would be unaffected. A preservation/storage protocol is critical for clinical translation,
giving the engineered product a “shelf-life.”
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7.2 Future Directions
7.2.1 Fabrication and Characterization of Tissue Engineered
Osteochondral Grafts
The incorporation of a porous base alters the nature of the engineered cartilage graft.
The base itself may block diffusion at locations in which the strut directly abuts the
gel; however, it may also increase diffusion as the base elevates the construct off the
culture dish bottom, exposing more surface area for diffusion [Bian et al., 2009a,Cigan
et al., 2014]. This aspect of growth may be tied to characteristics of the pore (e.g. size,
orientation, shape), which also influence the measured mechanical properties (Chapter
3, [Nover et al., 2015c]) and the ingrowth of bone [Bobyn et al., 1980, Bobyn et al.,
1999a]. Future studies will need to optimize these parameters through finite element
modeling and in vitro evaluation.
Further work is required to display culture of PCL-based constructs to native me-
chanical properties, though the results shown in 3.6 promote its feasibility. As per-
formed for titanium and tantalum in Chapter 3 (Tables 3.1 and 3.2, Figs. 3.1, 3.2,
and 3.3), the influence of the PCL’s pore structure will also need to be characterized
and then optimized. PCL can also be fabricated to specific geometries with great
precision [Lee et al., 2010,Lee et al., 2014,Mrosek et al., 2010,Moutos et al., 2010].
Additionally, future studies are needed to evaluate dynamic loading [Mauck et al.,
2000] for enhancing tissue growth of cell-seeded constructs on porous bases. A study by
Lima et al. models the porous base simply [Lima et al., 2004], predicting some benefit
of loading, however this does not account for displacement of the gel into the pores.
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Such displacement may diminish the effect of loading by decreasing local strains.
A bilayered base (Fig. 3.9), including an impermeable layer serving as a subchon-
dral plate [Hwang et al., 2008], may counter the undesirable displacement effects. Such
a base may be fabricated with optimal pore structure above and below the imperme-
able layer. Such bases will require evaluation. It is expected that a bilayered base, by
minimizing displacement into the base, will allow for greater interstitial fluid pressur-
ization, creating a graft with higher G* and thus more functionality than one without.
Likewise, such a base may lead to a more prominent dynamic loading effect. However,
growth with this a priori impermeable layer may be hindered by blocking of diffusion
as discussed in Chapter 4 [Bian et al., 2009a,Cigan et al., 2014].
As previously performed for tantalum-based engineered grafts [Ng et al., 2010], these
titanium and PCL-based osteochondral constructs will require evaluation in vivo. These
tests will lead to determination of preferred base material (e.g. metal or polymer) and
structural characteristics (e.g. strut thickness, pore size, and pore orientation).
7.2.2 Focused Ultrasound Approach for Local Tissue Property
Modulation
While the studies included in Chapter 4 promote HIFU as a method for altering local
tissue properties, much work is required to characterize and optimize the effect of
localized internal heating. First, a focused ultrasound transducer with a small focus
must be fabricated and evaluated, so to induce precise local effects. Studies described
in Chapter 4 utilize transducers fabricated for use on large areas.
HIFU heating parameters will need to be optimized so to get the maximum effect
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while minimizing cell death. Such parameter optimization may prove difficult since
they will depend on the acoustic nature of the tissue, which will change during culture
as ECM elaborates.
The mechanical and transport property alterations caused by HIFU will need to
be characterized and quantified on local and bulk scales. Increases in dynamic mod-
ulus [Lima et al., 2004] and integration strength (2.1.5.2) will be most important in
reproduction of the subchondral plate.
Proteins other than albumin, including those elaborated by the seeded chondrocytes,
will also need to be evaluated for their use as denaturable factors in this system. Though
albumin is commonly used [Chen et al., 2007,Divkovic et al., 2007, Iizuka et al., 1999,
Takegami et al., 2004,Hynynen, 1990] and relevant to the joint environment [Hui et al.,
2012], it is possible that another factor may provide a stronger effect. Additionally,
concentrations of heat-activated factors will require optimization to augment the desired
effect.
Once the effect is optimized, the timing of the application will also need to be
determined as the induced changes in transport and cell viability may be undesired at
early culture time points [Bian et al., 2009a,Cigan et al., 2014].
Ideally, treatment and effect of HIFU denaturation can be monitored by Harmonic
Motion Imaging [Maleke and Konofagou, 2008]. Elastographic information could be
used to confirm and characterize treatment. Currently treatment is confirmed by the
visualization of albumin denaturation.
Additionally, other applications of HIFU may be investigated including in situ heat
sealing of cartilage (engineered or native) grafts to surrounding tissue upon implantation
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and in vitro heat sealing of layered cell-seeded hydrogels [Cascio and Sharma, 2008,
Englert et al., 2007,Jürgensen et al., 1997,Sargeant et al., 2012,Sitterle et al.,
2009, Wang et al., 2007, Ng et al., 2005, DiMicco and Sah, 2001, Obradovic
et al., 2001]. It is expected that this technique may offer a wide variety of applications
as a precise tool.
7.2.3 Strategies for Scaling Up
The studies described in Chapter 5 show proof-of-principle for an interlocking subunit
method for scaling up engineered construct size. As a next step, construct shape, size,
and integration must be optimized through in vitro and in vivo studies. A size must
be chosen so to achieve native tissue properties. Likely a shape with volume less than
or equal to that of a 4 mm diameter, 2.3 mm thickness disk will allow for such tissue
elaboration. Interrelated to the size, the shape should allow room for assembly following
tissue swelling, while maximizing contact for integration between subunits.
This strategy should also be evaluated with incorporated osteochondral bases. Such
bases are expected to decrease tissue swelling due to the gel’s anchorage to the porous
base. They may also prevent separation of assembled subunits.
As displayed Chapter 5, integration of the assembled subunits is amplified by in-
creased individual or assembled culture. These effects could lead to a clinical scenario
in which mature grafts are assembled in situ or in which subunits are assembled in
vitro and subpunched or trimmed to size when implanted. In the former case, addi-
tional shapes will need to be designed to cap or plug the male and female parts of the
puzzle design. In the latter case, individual and assembled culture timelines must be
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evaluated and optimized so to yield functional and integrated large tissues. Note that
some osteochondral base materials, such as PCL, may allow for easy trimming.
Integration may be increased through caulking the assembled pieces [Cascio and
Sharma, 2008,Englert et al., 2007, Jürgensen et al., 1997,Sargeant et al., 2012,Sitterle
et al., 2009,Wang et al., 2007]. Such bioadhesives must be evaluated for this purpose,
ensuring integration without blocking of nutrients.
In vivo evaluation will be required to fully understand how these assembled pieces
will function upon implantation. This may depend on the utilized graft size as the
surrounding native tissue may shoulder loads in the case of smaller grafts.
Finally, this methodology should be applied to the engineering of large anatomic
constructs [Roach et al., 2015, Hung et al., 2003, Lee et al., 2014], subdividing the
structure into smaller interconnectable subunits.
7.2.4 Preservation/Storage of Engineered Grafts
The studies described in Chapter 6 represent promising first steps into preserving en-
gineered articular cartilage grafts. These studies show that engineered grafts respond
differently than native ones to storage. With this in mind, the preservation protocol
must be optimized to better maintain properties within the current transplantation
window of 28 days [Sherman et al., 2014]. Then, attempts must be made to extend this
window, as currently under investigation for native grafts [Cook et al., 2014b, Stoker
et al., 2012, Pallante et al., 2012, Bakay et al., 1998, LaPrade et al., 2009, Williams
et al., 2003,Williams et al., 2004,Williams et al., 2005,Williams et al., 2007,Teng et al.,
2008,Csönge et al., 2002,Ball et al., 2004,Bian et al., 2010b,Pylawka et al., 2008,Ma-
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linin et al., 2006, Allen et al., 2005, Garrity et al., 2012, Kwan et al., 1989, Pallante
et al., 2009, Rohde et al., 2004]. Current research suggests that cold storage may lead
to better long-term storage. Parameters to consider for optimization include storage
temperature, gas exchange, media change frequency, and media components such as
serum and growth factors.
Ideally, stored grafts will maintain mechanical, biochemical, viability, and metabolic
properties. The importance of each property may vary in terms of in vivo functionality.
An in vivo evaluation of preserved engineered grafts will be required to fully evaluate
the efficacy of the technique.
7.3 Concluding Remarks
Many challenges remain in the field of cartilage tissue engineering [Griffith and Naughton,
2002, Johnstone et al., 2013, Tan and Hung, 2011, Huey et al., 2012, Mauck and Bur-
dick, 2011, Gadjanski and Vunjak-Novakovic, 2015, Jeon et al., 2014, OConnell et al.,
2012, Johnson et al., 2010, Bertram et al., 2012, Madry et al., 2014]. This dissertation
presents four strategies, each addressing a different challenge: matching macrostructure
(Chapter 3), matching internal architecture (Chapter 4), increasing size (Chapter 5),
and maintaining properties in storage (Chapter 6). It is important to note that it is
expected that these strategies can be utilized in conjunction with each other as well
as in conjunction with other methods. Fig. 7.1 schematically depicts the synthesis of
these methods in the engineering and storage of a large anatomically shaped patella
construct. Additional barriers between the laboratory and the clinic include matching
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Figure 7.1: Synthesis of studies represented by the engineering of a large anatomically
shaped patella (shape adapted from [Hung et al., 2003]) by (A) culturing osteochondral
subunits (Chapters 3 and 5), (B) assembling them (Chapter 5), (C) sealing the interface
(Chapter 4), and (D) then storing the final product for implantation (Chapter 6).
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native anatomic shape [Hung et al., 2003,Roach et al., 2015,Lee et al., 2010,Lee et al.,
2014], increasing collagen production [O’Connell et al., 2014, Bian et al., 2009b, Na-
toli et al., 2009b, Natoli et al., 2009a, Ng et al., 2009, Responte et al., 2012, Anderson
and Athanasiou, 2009], advancing to large animal and human models [Cook et al.,
2014a, Gregory et al., 2012, Ahern et al., 2009], integrating engineered grafts with sur-
rounding native tissue [Cascio and Sharma, 2008,Englert et al., 2007,Jürgensen et al.,
1997, Sargeant et al., 2012, Sitterle et al., 2009, Wang et al., 2007, Obradovic et al.,
2001,Lima et al., 2004,Lima et al., 2008a,Nover et al., 2015c], passing regulation [John-
son et al., 2010, Bertram et al., 2012, Madry et al., 2014], and commercializing the
product [Johnson et al., 2010, Bertram et al., 2012, Madry et al., 2014]. In vivo trials
are essential, not only to confirm compatibility of the engineered grafts, but also to de-
termine the extent of engineering required for functional success [Miot et al., 2012, Jin
et al., 2011]. Overall, these four strategies move tissue engineering of articular cartilage
closer to clinical relevancy and translation.
Overcoming these challenges will secure engineered osteochondral grafts as an alter-
native to native allografts, providing additional replacement tissues as a treatment to
articular cartilage injury. Rather than relying on cadaveric tissues, the tissue engineer-
ing strategy would likely consist of cell harvest/acquisition and encapsulation (1.3.3.2,
2.1.1.1), cell encapsulation (1.3.3.1, 2.1.1.2), culture (1.3.3.3, 2.1.2), storage (6.1), and
then implantation through open joint surgery or arthroscopy. Engineered grafts may be
fabricated to offer patient-specific geometries and topographies or fabricated or to offer
general application depending on the cartilage injury [Hung et al., 2003, Roach et al.,
2015]. The strategies described in this dissertation apply to fabricating either of these
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engineered cartilage product options. Surmounting the aforementioned obstacles may
offer a diverse array of solutions so to best treat a large variety of cartilage injuries.
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